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Canine (K9) units and scientists developing explosives trace detection devices (ETDs) 
work with and are exposed to energetic materials when imprinting the dog or building 
instrument libraries. However, access to extremely hazardous materials, such as 
explosives, is limited, with a great need for training aids that provide a safe-handling and 
long shelf-life material. In order to address these needs, encapsulation of energetic 
materials, such as triacetone triperoxide (TATP), erythritol tetranitrate (ETN) and 
trinitrotoluene (TNT) in a polymer matrix have been developed, and extensively 
characterized to ensure explosive desensitization, controlled released, clean background 
odor and delivery of the pure explosive as effective training aids. Although, peroxide 
explosives, such as TATP and hexamethylene triperoxide diamine (HMTD) are a 
prominent threat, and their detection a priority within K9 units and ETD manufacturers, 
their absorption, distribution, metabolism and excretion (ADME) in the body have not been 
investigated. TATP is volatile and HMTD is lipophilic allowing for their inhalation and 
dermal absorption. Their distribution to the body was evaluated with blood incubations, 
which determined that TATP is stable for at least a week, while HMTD is degraded within 
minutes. Hepatic metabolism was investigated with microsomal and recombinant enzyme 
incubations. The metabolism of TATP undergoes hydroxylation catalyzed by cytochrome 
P450 2B6 (CYP2B6) to form TATP-OH, which undergoes glucuronidation catalyzed by 
uridine diphosphoglucuronosyltransferase 2B7 (UGT2B7) to form TATP-O-glucuronide, 
which was excreted in the urine of laboratory personnel and bomb-sniffing dogs exposed 
to TATP. Detection of these peroxide explosives and/or their metabolites in biological 
matrices (e.g. blood and urine) can be used as forensic evidence to exposure; therefore, 
 
 
paper spray ionization mass spectrometry was exploited as a robust analytical method for 
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This dissertation has been prepared in manuscript format in accordance with the guidelines 
of the Graduate School of the University of Rhode Island. The broad topic “Making 
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Encapsulation is proposed as a safer way of handling energetic materials. Different 
encapsulation methods for explosives, such as solvent evaporation, spray coating and 
supercritical carbon dioxide assisted encapsulation, were explored. Explosive training aids, 
where energetic materials, such as triacetone triperoxide (TATP), erythritol tetranitrate 
(ETN) and trinitrotoluene (TNT), are encapsulated in a polymer matrix were developed, 
followed by comprehensive quality control testing, including differential scanning 
calorimetry (DSC), thermogravimetric analysis-infrared spectroscopy (TGA-IR), gas 
chromatography-mass spectrometry (GC-MS), high resolution mass spectrometry 
(HRMS) and sensitivity testing, and finally field approved by canine units trained on the 
pure explosive.  
 
Keywords  














For detection instrumentation which functions by recognition of a compound by its 
unique vapor signature, a library of such signatures must be developed by training against 
authentic samples. In the case of detection of explosives, training aids may be necessary 
due to the uniquely hazardous nature of the material (J. C. Oxley, Smith, and Canino 2015); 
canine units (K9) or manufacturers of explosive trace detection (ETD) instruments may be 
deterred from working with them due to their limited availability and sensitivity. 
Encapsulation of a material is a well-recognized technique widely used in many industries 
(e.g. food, cosmetics, pharmaceuticals) for preservation and target-release (Madene et al. 
2006). Herein, we describe encapsulation as a method of creating a barrier between the 
explosive and the environment in order to make the explosives less detonable or improve 
the materials physical property.  
Encapsulation can be accomplished by several techniques, which can be 
categorized into chemical, such as interfacial polymerization, physico-mechanical and 
physico-chemical processes (Jyothi et al. 2010). An example of physico-mechanical 
process includes fluidized bed coating (also called Wurster coating) which uses air jets to 
move the core material past a nozzle that sprays the material with a solubilized or molten 
polymer. A similar process is reported here to encapsulate ammonium nitrate (AN) (Jyothi 
et al. 2010; Suganya and Anuradha 2017). 
Physico-chemical processes, such as solvent evaporation and supercritical CO2 (sc-
CO2) assisted encapsulation, were used to develop the training aids. Solvent evaporation 





polymer and core material and for the continuous phase, a solvent, usually aqueous, 
immiscible in first, to create droplets which harden into solid microspheres as the solvent 
evaporates (Li, Rouaud, and Poncelet 2008; O’Donnell and McGinity 1997). Supercritical 
CO2 assisted encapsulation can be done by two methods: rapid expansion of supercritical 
solution (RESS) and supercritical anti-solvent (SAS). RESS consists of dissolving the 
polymer and core material into supercritical fluid. This pressurized solution is sprayed into 
a region at atmospheric pressure, thus forming particles. However, we found that polymer 
solubility in supercritical-CO2 is challenging. More accommodating was the SAS method, 
where both the polymer and core material are dissolved in a soluble solvent, but become 
insoluble when the solution is introduced into supercritical fluid, forcing the materials to 
co-precipitate. This method was used to encapsulate explosives with poor solubility (Jyothi 
et al. 2010; Soh and Lee 2019). 
The core materials that were investigated, encompassed most explosives classes: a 
nitroaromatic, e.g. trinitrotoluene (TNT); a nitrate-ester, e.g. erythritol tetranitrate (ETN); 
and a peroxide, e.g. triacetone triperoxide (TATP), were initially screened for training aids. 
TNT, the military explosive standard, is a secondary high explosive, insensitive to impact, 
friction and static but with a detonation velocity of 6.93 km/s (Dobratz 1972). On the other 
hand, an easily synthesized from household items material, TATP, is a primary high 
explosive, its sensitivity allows for easy initiation which may be used to trigger the 
secondary charge (J. C. Oxley et al. 2013). ETN has recently been emphasized because, 





(J. C. Oxley et al. 2012), and similarly to TNT, it can be melt cast, expanding its potential 
usage (J. C. Oxley, Smith, and Brown 2017). 
Explosives have been encapsulated for various purposes (Brewer, Staymates, and 
Fletcher 2016; Elzaki and Zhang 2016; Liu et al. 2017). Using encapsulated explosives as 
training aids for canine or detection instrumentation requires extensive quality control. This 
includes reproducible synthesis conditions to ensure clean background vapor which 
requires pre- and post-reaction processing to guarantee polymer compatibility and solvent 
removal. Furthermore, sufficient explosive vapor must be released only when triggered to 
provide a non-hazardous, safe to handle, material and deliver a pure explosive scent. We 
have previously demonstrated the encapsulation of TATP (J. C. Oxley, Smith, and Canino 
2015). Herein, we report additional explosives which have been encapsulated, and more 






Materials and Methods 
Chemicals 
Energetic materials, such as triacetone triperoxide (TATP) (J. C. Oxley et al. 2013), 
erythritol tetranitrate (ETN) (J. C. Oxley et al. 2012), trinitrotoluene (TNT), 
hexamethylene triperoxide diamine (HMTD) (J. C. Oxley et al. 2016), pentaerythritol 
tetranitrate (PETN) and cyclotrimethylenetrinitramine (RDX) were either purchased or 
synthesized. Optima LC-MS grade methanol, Optima LC-MS grade water, ACS grade 
acetone, ACS grade dichloromethane (DCM), ammonium nitrate (AN), ammonium acetate 
and ammonium chloride were purchased from were purchased from Fisher Chemical (Fair 
Lawn, NJ, USA). Poly(vinyl alcohol) (PVA), polyetherimide (PEI) and ACS grade 
dichloromethane (DCM) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Polycarbonate (PC), polystyrene (PS) and poly(methyl methacrylate) (PMMA), ethoxyl 





The solvent evaporation method consisted of creating a dispersed organic phase in 
a continuous aqueous phase. The dispersed phase included the core material (1 g explosive) 
and the matrix material (2 g polymer) dissolved in a volatile solvent (20-30 mL DCM). 
The continuous phase was a surfactant aqueous solution (200 mL of 2% PVA aqueous 





stirred (900 rpm) with the aid of a mixer. The two phases system were set to stir; the 
polymer, being insoluble in water, precipitates around the core material as the volatile 
solvent slowly evaporates from the solution, forming microspheres which are particles of 
the core material dispersed in a polymer matrix (Li, Rouaud, and Poncelet 2008; O’Donnell 
and McGinity 1997). The microspheres were washed with copious amounts of water prior 
to vacuum filtration and collection. Encapsulation of ETN and TNT was done using the 
solvent evaporation method previously described for TATP microspheres (J. C. Oxley, 
Smith, and Canino 2015). However, for optimization and potential scale-up some 
parameters were adjusted by varying volume and type of solvents, volume and 
concentration of surfactant, solvent-to-emulsifier ratio, polymer-to-explosive ratio, size of 
reaction vessel and reaction time. Different solvent removal techniques were tried to 
remove the large volume of solvent or co-solvent system required to dissolve HMTD, 
PETN or RDX, such as increasing the temperature of the continuous phase or continuous 
dilution of the continuous phase (Jyothi et al. 2010; Jeyanthi et al. 1996); however, 
encapsulation of these explosives was not successful.  
 
Supercritical carbon dioxide (sc-CO2) assisted encapsulation 
 A Waters Hybrid RESS/SAS (Rapid Expansion of Supercritical 
Solution/Supercritical Anti-Solvent) system (Waters Corporation, Milford, MA, USA) was 
used for the synthesis of training aids by the supercritical carbon dioxide (sc-CO2) assisted 
encapsulation. The method, SAS (Prosapio, De Marco, and Reverchon 2018), consisted of 





100 mL DCM) and spraying it into a chamber filled with sc-CO2., which was reached at 
the critical pressure, 74 bar, and critical temperature, 31.3 °C (Parhi and Suresh 2013). The 
sc-CO2 extracted the solvent from the solution droplets, co-precipitating polymer and 
explosive into microspheres. Usual encapsulation procedure consisted of dissolving 
different ratios of polymer and the explosive in DCM and flowing the solution at a rate of 
0.5mL/min into the sc-CO2 filled chamber. The instrument settings were as follows: CO2 
flow rate of 20 g/min, the electric heat exchanger temperature was 80 °C, the reaction 
vessel heater temperature was 75 °C, the cyclone heater temperature was 10 °C, and the 
pressure was 150 bar. The main adjustment parameters included the concentration of the 
polymer explosive solution, the flow rate of the solution into the supercritical chamber, the 
pressure of the CO2 chamber, the temperature of the CO2 chamber, and addition of co-
solvents to the CO2 chamber, e.g. encapsulation of HMTD with PC was achieved by adding 
10 mL water to the CO2 chamber. 
 
Spray coating 
Ammonium nitrate (AN) encapsulation was done using a Resodyn LabRAM 
acoustic mixer coupled with an Sonozap Ultrasonic Atomizer spray coater (Resodyn, 
Butte, MT, USA) (Ivosevic, Coguill, and Galbraith 2009). Due to the hygroscopic nature 
of AN, a drying process before encapsulation was necessary. Pre-dried AN (core material, 
200 g) was placed in the acoustic mixer under vacuum. A solution of a hydrophobic 
polymer (shell material, 2 g), either PMMA or EC in acetone (25 mL) was placed in the 





on the AN; the vacuum removed the solvent; and the polymer coated the AN surface. The 
LabRAM uses acoustic energy in the form of intense vibrations, that creates an almost 
fluidized state, allowing for an even surface coating (Bhaumik 2015). Encapsulation 
optimization included varying the acoustic mixer acceleration (10-20 G`s) and intensity 
(10-50 %), vacuum pressure (3-10 psi), syringe pump flow rate (0.1-0.5 mL/min), atomizer 
power (50-90%), and number of coatings (1-4).  
 
Instrumental analyses 
Imaging by polarized light microscope (PLM) 
A Nikon Eclipse E400 POL Polarized Light Microscope (PLM; Nikon, Tokyo, 
Japan) was used to examine the particle size and shape of the training aids. 
 
Thermal-gravimetric analyzer coupled to infrared spectrometer (TGA-IR) 
A Q5000 thermal-gravimetric analyzer (TA Instruments, New Castle, DE, USA) 
was coupled to Nicolet 6700 Fourier transform infrared spectrometer (TGA-IR). The off-
gas of core material from the TGA was routed through a heated transfer line to the infrared 
spectrometer for quantification and identification. The furnace and scale of the TGA were 
purged with nitrogen gas, at a flow rate of 25 and 10 mL/min, respectively. The TGA was 
set to ramp at 20 °C/min from 40 °C to 300 °C, for TATP and ETN analysis, and to 500 
°C for TNT analysis. The transfer line and the 20 cm path length vapor cell were kept at 
150 °C. IR spectra were collected at 32 scans with a spectral resolution of 4 cm-1. 





°C/min from 40 °C to 1000 °C, with the off-gas uncoupled to the IR. Infrared (FT-IR) 
spectra with detection mode attenuated total reflection (ATR) were collected at 32 scans 
with a spectral resolution of 4 cm-1. All samples (about 10 mg) were ran in duplicate, with 
two samples from each of the various training aids (n = 4). 
 
Differential scanning calorimeter (DSC) 
A TA Instruments differential scanning calorimeter (DSC) Q100 (TA Instruments, 
New Castle, DE, USA) was used to assess encapsulation efficiency. The DSC was set to 
ramp at 20 °C/min from 40 °C to 450 °C with nitrogen gas purge at 50 mL/min for TATP, 
ETN and TNT analysis. Decomposition temperature (Td) of polymers was determined by 
DSC using the same heating method. AN analysis was done at a ramp of 20 °C/min from 
-30 °C to 300 °C. All samples (1 ± 0.05 mg) were sealed in hermetic aluminum pans and 
ran in duplicates, with two samples from each of the various training aids (n = 4). Glass 
transition temperature (Tg) of polymers was determined by ramping 5 °C/min from 40 °C 
to 250 °C, then ramping back down at a rate of 10 °C/min to -50 °C, and cycling back up 
at 5 °C/min to 250 °C. 
 
Gas chromatography-mass spectrometry (GC-MS) 
Gas chromatography mass spectrometry (GC-MS), an Agilent 6890N GC system 
coupled to an Agilent 5973N Mass Selective Detector (Agilent Technologies, Santa Clara, 
CA, USA), was used to characterize the background vapor released from the training aids. 





headspace vial containing approximately 50 mg of the microspheres at 150 °C for 1 min, 
and injecting the headspace vapor (1mL) into a GC-MS. The method for TATP (J. C. 
Oxley, Smith, and Canino 2015) and ETN (J. C. Oxley et al. 2012) analysis were previously 
described. The method for TNT analysis was as follows: The vapor released from the 
training aids was injected into the splitless GC inlet set to temperature 260 °C. The GC 
column was an Agilent J&W VF-200ms (15m X 0.25mm i.d., particle size 0.25μm). The 
mode of operation was constant flow at 1.5 mL/min. The initial oven temperature, 110 °C, 
was held 5 min, followed by a ramp of 10 °C/min to 280 °C with a 5 min hold. The MS 
transfer line was kept at 285 °C. MS analysis was carried out using electron impact (EI) 
ionization (70 eV) with a scanning range of m/z 20-500 at a rate of 2 scan/s, and 1.5 min 
solvent delay.  
 
Direct infusion high-resolution mass spectrometry (HRMS) 
Direct infusion into the Thermo Scientific Exactive high resolution mass 
spectrometer (HRMS; Thermo Scientific, Waltham, MA, USA) was used to verify that 
intact explosive was present in the vapor phase. Since the encapsulated material is released 
by heat, the training aids were tested by baking a headspace vial containing approximately 
50 mg of the microspheres at 150 °C for 1 min. The headspace vapor (5 mL) was dissolved 
in 500 μL of methanol/aqueous solution (1:1, v/v) and directly infused it into a HRMS at a 
flow rate of 10 μL/min. The aqueous solution consisted of 10mM ammonium acetate for 





nitrate and 0.1% formic acid for TNT and ETN. The MS tune conditions for TNT, TATP 





Table 1-1. High resolution mass spectrometer tune conditions 
Parameters TNT (ESI–) TATP (APCI+) ETN (ESI–) 
Spray voltage (kV) -4.2 N/A -3 
Discharge current (µA) N/A 5 N/A 
Vaporizer temperature (°C) N/A 220 N/A 
N2 sheath gas flow rate (AU) 15 15 11 
N2 auxiliary gas flow rate (AU) 2 4 0 
Capillary temperature (°C) 250 220 150 
Capillary voltage (V) -25 30 -28 
Tube lens voltage (V) -80 45 -130 
Skimmer voltage (V) -18 14 -20 
N/A not applicable; AU arbitrary units; ESI- electrospray ionization (negative mode); 







Explosive sensitivity tests 
Explosive sensitivity tests were done to determine the sensitivity to detonation of 
the training aids when exposed to friction, electrostatic and impact.  
Impact sensitivity (AOP-7 U.S. 201.01.001) was done using a custom type 12 
system. Varying impact energy values, established by applying varying heights from which 
to drop a specific weight (m = 3.9 kg), were applied to the sample (about 35 ± 5 mg) until 
50 % probability of impact initiation was reached, determined by the Bruceton method.  
Friction sensitivity (AOP-7 U.S. 201.02.006) was measured using a BAM Friction 
Apparatus FSA-12 (OZM Research, Hrochuv Tynec, Czech Republic). Varying friction 
force values, established by applying varying mass and distance, were applied to the sample 
(2-5 mg) until 50 % probability of friction initiation was reached.  
Electrostatic sensitivity was measured using an ESD 6 (UTEC Corporation, 
Riverton, KS, USA) in accordance to MIL-STD-1751 method 4. Varying electrostatic 
energy values, established by applying varying capacitance and voltages, were applied to 






Results and Discussion 
Trace Explosives Aids for Scent (TEAS) 
Characterization 
Thermoplastics were selected for the training aids because they are stable at high 
temperatures (Kawaguchi et al. 2005); nevertheless, the decomposition of the polymers 
selected for encapsulation was screened by TGA and DSC. Thermal degradation of the 
polymers by TGA showed one mass loss for PC and PEI with 77 % decomposition around 
539 °C and 49% decomposition around 554 °C, respectively. PS completely decomposed 
around 429 °C, and PMMA had two mass losses, with complete decomposition around 397 
°C (Table 1-2, Figure A-1). TGA traces indicated that PC, PEI and PS were stable in the 
desired temperature range with less than 0.1% mass loss by 300 °C. On the other hand, 
PMMA lost 0.2% mass by 100 °C, and the PMMA IR spectrum indicated decomposition 
as temperature increased, with methacrylate derivatives peaks matched to the IR library. 
DSC showed no decomposition from PC nor PEI until 450 °C (temperature limit of the 
instrument), but PS and PMMA showed initial decomposition around 378 °C and 344 °C, 
respectively (Table 1-2, Figure A-2). The similar thermal degradation patterns observed 
from both the TGA and DSC, suggest that PC, PEI and PS are suitable polymers for 










Table 1-2. Summary of DSC results for thermoplastics 
Polymers 





































PC 539 9 77 0      148 0      
PS 429 2 100 0      104 0  378 3 incomplete 
PMMA 302 6 5 0 397 9 95 0  118 0  344 2 859 166 
PEI 554 11 49 2      216 0      








      
    
 
Microscopy of the encapsulated explosive showed them as spherical white particles 
with particle size, averaging around 50-150 μm (Figure 1-1). The solvent evaporation does 
not produce absolute capsules since the core material is distributed within the polymer 
matrix instead of encircled by it. Since the encapsulated material is the micrometer range 





      
    
 
 
Figure 1-1. Image of TATP, ETN and TNT encapsulated with PEI 
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Release of the encapsulated explosive (the core material) is accomplished by heat; 
therefore, the first method to assess encapsulation was TGA-IR. The explosive was 
released from the polymer shell as the sample was heated at a set rate by TGA; the vapor 
released was channeled to the IR to confirm the release of the explosive. The method not 
only analyzed the purity of the vapor, but the weight loss, at the temperature releasing 
vapor, was used to evaluate the explosive loading of the microspheres, reported as percent 
mass loss (Table 1-3). The explosive release temperature was assigned from the TGA as 



























































TATP 94 6 98 1         
PC-TATP 148 1 15 0         
PS-TATP 98 1 1 0 175 1 14 1     
PMMA-TATP 136 1 6 0 215 1 39 1     
PEI-TATP 194 0 32 0         
ETN 177 4 100 0         
PC-ETN 192 1 27 0         
PS-ETN 185 1 26 0         
PMMA-ETN 194 0 33 0 267 1 24 0     
PEI-ETN 198 1 30 0         
TNT 242 10 100 0         
PC-TNT 241 10 32 0         
PS-TNT 240 14 27 0         
PMMA-TNT 259 11 35 0         
PEI-TNT 115 3 1 0 202 1 11 2 286 5 21 2 
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The TGA thermograms of the TATP microspheres with different polymers are 
shown in Figure 1-2. PC-TATP had a mass loss of about 15 % at 148 °C (Table 1-3), 
indicating that the microspheres can be triggered to release the explosive by heating them 
at this temperature, and that the explosive loading is about 15 % of the total microspheres. 
The IR spectrum from the vapor released from PC-TATP around 148 °C matches the IR 
spectrum of TATP vapor (Figure 1-3), with corresponding characteristic peaks at 942 cm-
1 (ring O-O asymmetric stretch), 1194 cm-1 (O-C-O and H3C-C-CH3 asymmetric stretch), 
2953 cm-1 (methyl substituent C-CH3 symmetric stretch) and 3007 cm
-1 (aliphatic C-C 
symmetric stretch) (Mamo and Gonzalez-Rodriguez 2014; J. Oxley et al. 2008), indicating 











Figure 1-2. TGA thermograms of TATP encapsulated with various polymers 
 
 






Figure 1-3. Overlaid IR spectra of the vapor released from pure TATP compared with the vapor released from TATP encapsulated with 
various polymers (corresponding to the largest mass loss from the thermograms illustrated on Figure 1-2) 
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Curiously, the thermogram of PS-TATP indicated two consecutive mass losses, 
first 1 % at 98 °C and second 14 % at 175 °C (Table 1-3), but the IR spectrum from both 
mass losses corresponded to that of TATP. The TGA of PEI-TATP showed an abnormally 
high mass loss of about 32 % at 194 °C (Table 1-3); however, the IR spectrum of the vapor 
released at that mass loss indicated a contaminant, since it exhibited an extra peak at 1776 
cm-1 (Figure 1-3), which is characteristic of an imide carbonyl stretch consistent with the 
chemical structure of PEI (Chen et al. 2006). Considering PEI did not decompose until 
higher temperatures (554 °C), this PEI leaching around 194 °C suggests chemical 
interaction with TATP is promoting early degradation (Figure 1-3). 
The IR spectra of the vapor released from PMMA-TATP (Figure 1-3) and PMMA-
ETN (Figure A-3) contained peaks characteristic of methyl methacrylate at 1167 cm-1 (C-
O-C), 1636 cm-1 (C=C vinyl) and 1749 cm-1 (C=O ester) (Sugumaran, Juhanni, and Karim 
2017). Kashiwagi have described the thermal degradation of PMMA into its monomer at 
temperatures above 200 °C (Kashiwagi et al. 1986), suggesting that the heating process 
necessary to release the core material from the microspheres is also degrading the polymer 
and contaminating the background odor of the spheres. Evaluations such as this, led to final 
selection of the encapsulating polymers. 
The TGA thermograms of PC-ETN, PS-ETN and PEI-ETN indicated the explosive 
loading of 27, 26, and 30 %, with vapor release at 192, 185 and 198 °C, respectively 
(Figure A-4). The IR spectra from the vapor released from these microspheres matches the 
IR spectrum of pure ETN (Figure A-3), with corresponding characteristic peaks at 837 cm-
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1 (ester O-N stretch), 1276 cm-1 (symmetric NO2 stretch) and 1630 cm
-1 (asymmetric NO2 
stretch) (Oleske et al. 2015; Manner et al. 2014; McNesby and Pesce-Rodriguez 2002; 
Urbanski and Witanowski 1963), indicating that the mass losses observed in the TGA 
corresponds to the explosive being released. 
The core material is released from the microspheres by heat; however, little is 
known about its mechanism. Glass transition temperature has been suggested to be 
involved in the release mechanism (Omelczuk and McGinity 1992). The TATP release 
temperature from the PC-TATP and PS-TATP (Table 1-3) coincided with the glass 
transition temperature of those polymers, 148 and 104 °C, respectively (Table 1-2, Figure 
A-5), suggesting the mechanism of release occurs as the polymer changes from a glassy to 
a soft material. On the other hand, the ETN release temperature from all polymers was 
around 192 °C (Table 1-3), which correlates to the exothermic decomposition of ETN, 185 
°C (Table 1-4). This data suggests the mechanism of release is dependent on the properties 
of the explosive and not on that of the encapsulation material. Therefore, neither the glass 
transition temperature of the polymer nor the vaporization temperature of the explosive can 









































































TATP 98 0 121 4 193 9 1245 80          
PC-TATP     198 2 174 46          
PS-TATP     204 0 205 14 379 3 210 5      
PMMA-TATP 180 3 10 1     217 3 29 2 367 3 222 36 
PEI-TATP 91 0 9 0 177 1 398 60          
ETN 61 0 121 8 185 5 796 22         
PC-ETN 61 0 20 3 183 1 297 23         
PS-ETN 61 1 38 4 182 2 479 203 360 7 205 4     
PMMA-ETN     184 2 744 106         
PEI-ETN     188 2 668 75         
TNT 81 0 95 3 311 5 1164 62         
PC-TNT 58 1 5 0 325 2 669 116         
PS-TNT 80 0 23 1 290 8 390 191 383 10 129 8     
PMMA-TNT     296 2 570 112         
PEI-TNT     297 1 684 33         
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The thermograms of PC-TNT, PS-TNT and PMMA-TNT had a mass loss of 32 % 
at 241 °C, 27 % at 240 °C and 35 % at 259 °C, respectively (Figure A-6); furthermore, the 
TGA of PEI-TNT showed three mass losses of 1, 11 and 21 % at 115, 202 and 286 °C, 
respectively. Unfortunately, IR vapor analysis at these specific mass losses could not be 
obtained because the TNT vapor condensed in the transfer line connecting the TGA to the 
IR vapor cell. 
Trace Explosive Aids for Scent (TEAS) are intended for construction of ETD 
library databases and dog scent imprinting; therefore, a clean background odor is essential. 
For that reason, GC-MS verification of the vapor released from the microspheres was 
performed. The chromatograms of the vapor released from the TATP (Figure A-7) and 
TNT (Figure A-8) microspheres with PC, PS and PEI showed a clean background with 
peaks corresponding to the retention time of only the respective explosive. The 
chromatograms of the vapor released from PMMA-TATP, PMMA-TNT and PMMA-ETN 
included an additional peak that did not match the explosives; and although no mass 
spectral library match was obtained, polymer degradation was likely, as suggested from 
the IR data.  
In addition to the issues pertaining to polymer thermal degradation, there were 
additional problems with contaminants present in the polymers’ starting material. 
Unfortunately, these impurities did not necessarily appear under all chromatographic 
conditions. Using the gentle chromatographic method employed for the easily degradable 
ETN (Figure 1-4), i.e. a short chromatographic column and low starting temperature, 
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styrene, the monomer of PS, and dichlorobenzene, the solvent used in polymerization of 
PEI (Chiong et al. 2017; Bookbinder, Peters, and Cella 1988), were observed in the blank 
microspheres of their corresponding polymers (Figure A-9). This emphasizes the need for 
pre-cleaning the polymers before encapsulation which was accomplished by heating the 
polymer under vacuum, or heating the polymer under high pressure using the Rapid 
Expansion of Supercritical Solutions (RESS), or dissolving and re-precipitating the 







      
    
 
 
Figure 1-4. Overlaid GC chromatogram, with magnification around the baseline, of the 
vapor released from pure ETN compared with the vapor released from ETN encapsulated 
with various polymers at 150 °C for 1 min 
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The mass spectra of the vapor released from the TATP, TNT and ETN 
microspheres observed from GC-MS experiments matched the retention time and literature 
mass spectra by EI ionization of the pure explosive. The EI fragmentation pattern (Figure 
A-10) of TATP (characterized by m/z 43, 58, 59, 75) (ATF 2018), ETN (characterized by 
m/z 30, 46, 60, 76, 89, 151) (J. C. Oxley et al. 2012), TNT (characterized by m/z 63, 89, 
134, 149, 164, 180, 193, 210) (ATF 2018), all matched the mass spectra of the vapor 
released from the corresponding microspheres. However, molecular ions for these 
explosives were not observed under standard EI conditions.  
To confirm that the explosives did not degrade while the microspheres were heated, 
their released vapor were dissolved in a solvent and directly infused into an HRMS. All 
TATP microspheres had m/z 240.1442, corresponding to [TATP+NH4]
+; all ETN 
microspheres had m/z 363.9866, corresponding to [ETN+NO3]
-; and all TNT microspheres 
had m/z 226.0106, corresponding to [TNT-H]-, indicating that the explosives did not 





      
    
 
 
Figure 1-5. Full scan mass spectrum of TATP, ETN and TNT encapsulated with PS using 
APCI+ for TATP and ESI- for ETN and TNT on a Thermo Exactive HRMS 
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DSC was another quality control technique used to evaluate encapsulation (Table 
1-4). Encapsulation consists of non-covalent interactions between the core and shell 
material, in which both retain their intrinsic properties (e.g. melting point). However, the 
disappearance of the melting endotherm of the core material suggests an inclusion 
complex, where the shell material completely surrounds the core (Grandelli et al. 2013). 
The DSC thermogram of TNT encapsulated with PS (Figure 1-6) indicates their intrinsic 
properties are preserved; only the TNT endothermic and exothermic peaks were observed 
(no polymer peaks should be observed in this range). In the thermograms of PMMA-TNT 
and PEI-TNT, the TNT melting peak disappeared, suggesting the formation of an inclusion 
complex. In the thermogram of TNT encapsulated with PC, the melting point of TNT 
shifted to lower temperature, which is usually an indication of impurities contaminating 
the thermogram. Encapsulated ETN either exhibited an endotherm which was an exact 
match to that of pure ETN, observed with PC and PS; or the endotherm of melt completely 
disappeared, observed with PMMA and PEI (Figure A-11). In the DSC thermograms of 
PC-TATP and PS-TATP the TATP melting endotherm was absent. However, the DSC of 
PMMA-TATP did not resemble the thermograms of either the core or shell material; and 
the DSC of PEI-TATP showed a decrease in the endothermic peak of TATP from 98 °C to 
91 °C (Figure A-12), suggesting some decomposition and/or impurities, which was noted 










Figure 1-6. DSC thermogram of pure TNT compared with TNT encapsulated with different polymers 
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Explosives are classified based on their sensitivity to detonation when exposed to 
impact, friction and/or electrostatic. DFT calculations of energetic materials encapsulated 
in carbon nanotubes have predicted that explosives are stabilized upon encapsulation, 
proposing that, as a consequence, their sensitivity would be reduced (Smeu et al. 2011). 
Therefore, sensitivity testing (Table 1-5) was done to ensure that encapsulation decreased 
the explosives sensitivity, converting them to a less hazardous material that can safely be 
handled. TATP is a primary explosive (Gerber, Walsh, and Hopmeier 2014), considered 
extremely sensitive, but encapsulation desensitized TATP. All polymers significantly 
decreased the sensitivity of TATP to impact, friction and electrostatic, although PEI 
appears to be least effective polymer in decreasing the impact and friction sensitivity of 
TATP. Encapsulation of ETN greatly decreased its impact (Matyas and Künzel 2013), 
friction (Matyas and Künzel 2013) and electrostatic sensitivity, especially with PMMA and 
PEI which prevented ETN from reacting even at the maximum friction force (360 N) or 
drop height (2.838 m). TNT is a secondary explosive (Trzciński et al. 2014), deemed 
insensitive, and although encapsulation did not affect its friction sensitivity, encapsulation 





      
    
 









TATP 12 <0.5b 3-4 
PC-TATP >108a >360a 563-606 
PS-TATP >108a >360a 792-3001 
PMMA-TATP >108a >360a 309 
PEI-TATP 34 28-30 563 
ETN 24 14-56 29-46 
PC-ETN 48 120-144 309 
PS-ETN 41 144-360 276-309 
PMMA-ETN >108a >360a 203 
PEI-ETN >108a >360a 124-150 
TNT 63 >360a 141-360 
PC-TNT >108a >360a 446-456 
PS-TNT >108a >360a 456 
PMMA-TNT >108a >360a 309 
PEI-TNT >108a >360a 446 
a greater than instrument maximum  









      
    
 
Field Testing 
IMS and canines are placed in most ports of entry for screening of people and cargo 
to detect explosives and other contraband (Brown et al. 2016). Therefore, IMS testing of 
these encapsulated explosives was imperative to ensure that they would perform as 
effective training aids in field. Encapsulated explosives were deposited on a swab, and the 
swab was analyzed using a Morpho Detection Itemizer IMS (Morpho Detection, Newark, 
CA, USA). TATP and TNT encapsulated with any of the polymers alarmed as the 
corresponding explosive in tests run in triplicate. However, ETN training aids indicate 
some false negatives, once with PS and PEI, and twice with PC and PMMA. 
Bomb-sniffing dogs are imprinted on explosive odor by “operant conditioning” (K. 
G. Furton and Myers 2001; K. Furton, Greb, and Holness 2010). Briefly, small containers 
with explosives are hidden in multiple locations, as the handler slowly walks the dog, 
allowing it to sniff and sit when it recognizes the explosive odor, expecting a positive 
reward. The K9 unit evaluation of our training aids consisted of: 1) placing about 50 mg of 
microspheres in a small vial (7 × 50 mm) plugged with a pre-cleaned cotton swab, 2) 
heating the microspheres with a purpose-built heater (DetectaChem®), and 3) once the 
explosive had condensed on the swab, proceeding with the normal training routine, using 
the swab instead of bulk explosives (Figure 1-7). The bomb-sniffing dogs, imprinted on 




      
    
 
Encapsulation allows the training aids a long shelf-life, controlled release, and safe 
handling of otherwise sensitive materials. Containing only trace amounts of pure 
explosives, they are a valuable alternative to handling hazardous materials in the field. 
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Supercritical CO2 assisted encapsulation 
Since post-reaction treatment to eliminate solvent remnants from the training aids 
decreased throughput, an encapsulation method that did not require solvent was needed. In 
addition, a method that would allow encapsulation of HMTD, PETN and RDX was wanted, 
since they have poor solubility in DCM and other suitable solvents, required for the solvent 
evaporation method. In order to improve the production of training aids, supercritical CO2 
assisted encapsulation was attempted. The advantages of using supercritical CO2 for the 
encapsulation of explosives include use of low temperatures which minimizes the risk of 
decomposition, solvent absence which reduces the processing time and increases 
throughput, and polar and nonpolar compounds suitability which accommodates most 
explosives and co-solvents. 
Although the thermogram of TNT (Teipel, Gerber, and Krause 1998) encapsulated 
in PEI demonstrated a small mass loss of 4-5 %, it was consistent within trials, 
demonstrating proof-of-concept (Figure 1-8). Reproducibility issues of HMTD 
encapsulation were observed using both solvent evaporation (Figure A-13) and sc-CO2 
assisted encapsulation, as illustrated in the Figure 1-9 thermogram where the first trial 
indicated a mass loss of 6.5 %, demonstrating encapsulation and release of the core material 












Figure 1-8. TGA thermogram of sc-CO2 PEI-TNT made under the same SAS method conditions 
 
 






Figure 1-9. TGA thermogram of sc-CO2 PC-HMTD made under the same SAS method conditions 
42 
 
      
    
 
Spray coating 
The energetic material community can benefit from using encapsulation in areas 
other than manufacturing training aids. For example, encapsulation of AN can significantly 
reduce its hygroscopicity, and, as a consequence, improve its fuel efficiency to be used as 
a green solid rocket propellant (Chaturvedi and Dave 2013). Figure 1-9 illustrates the 
standard five phase transitions of AN. At 32 °C, AN undergoes the phase transition IV  
III, which is associated with a large volume change. This volumetric change may cause 
material cracking, which can initiate irregular burns, rendering the material impractical as 
a propellant (Lang and Vyazovkin 2008; Chaturvedi and Dave 2013). However, in the 
absence of water, phase transition III is absent; and the transition IV  II occurs around 
50 °C (Lang and Vyazovkin 2008; Kiiski 2009). Therefore, a polymer shell of PMMA 
(Figure 1-10) or EC (Figure A-14) was spray coated onto AN to prevent the uptake of 
water (Figure 1-10), avoid the phase transition III, decrease the AN volume variation, and 
solve the issues with abnormal burning. Spray coating produced a capsule which 
surrounded the AN with a hydrophobic barrier that prevented AN from absorbing water. 
The IR spectrum of PMMA coated AN demonstrated the presence of the polymer on the 
surface of the encapsulated AN. PMMA-AN has two peaks at 1727 and 1754 cm-1. The 
latter corresponds to the AN peak at 1754 cm-1 (Figure 1-11); and the former, to the 
PMMA peak at 1722 cm-1 (C=O stretching vibration) which became more prominent as 










Figure 1-10. DSC thermogram of pure AN compared with AN coated with PMMA stored at room temperature for 6 months 
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Figure 1-11. Overlaid IR spectrum of AN coated PMMA compared with either pure AN 
or pure PMMA 
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Conclusions 
TATP, TNT and ETN have been encapsulated using the solvent evaporation 
method. The use of these encapsulated materials as training aids for ETD manufacturers 
and K9 units training has several advantages: the polymer protective shell allows the 
material to be stored at room temperature and provides explosivity protection, since the 
microspheres are insensitive to impact, friction and electrostatic, rendering them safe to 
handle; and thorough quality control tests ensure a clean background odor, no 
decomposition upon heating release, and a pure explosive vapor. 
Results from each of the quality control techniques used to characterize these 
training aids determined that PC and PS are suitable polymers for TATP encapsulation 
with about 15 % TATP released around 162 °C, PS and PEI are suitable solvents for TNT 
encapsulation with about 30 % TNT released around 242 °C, and PC, PS and PEI are 
suitable polymers for ETN encapsulation with about 28 % ETN released around 192 °C 
(Table 1-3); however, considering the impurities found in the pure polymers, PS and PEI, 
these are not adequate for encapsulation unless a thorough pre-cleaning process is 
implemented.  
Supercritical CO2 assisted encapsulation was performed with TNT, showing proof-
of-concept. However, to date, this technique has not increased throughput, nor allowed for 
scale-up of the training aids made using the solvent evaporation method, nor did it expand 
the training aids selection to permit more explosives to be encapsulated. Spray coating 
successfully encapsulated AN with PMMA and EC, preventing the uptake of water, 
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avoiding the phase transition III, and decreasing the AN volume variation. As a 
consequence, the coating increased the shelf-life of the dry AN and, perhaps, solving the 
issues with abnormal burning, thus, making it an effective green propellant. Encapsulation 
is a versatile tool that can be further exploited, in addition to the practical application 
demonstrated, the use of training aids, from encapsulating explosives. 
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Purpose Triacetone triperoxide (TATP) is a volatile but powerful explosive that appeals to 
terrorists due to its ease of synthesis from household items. For this reason, bomb squad, 
canine (K9) units, and scientists must work with this material to mitigate this threat. 
However, no information on the metabolism of TATP is available.  
Methods In vitro experiments using human liver microsomes and recombinant enzymes 
were performed on TATP and TATP-OH for metabolite identification and enzyme 
phenotyping. Enzyme kinetics for TATP hydroxylation were also investigated. Urine from 
laboratory personnel collected before and after working with TATP was analyzed for 
TATP and its metabolites. 
Results While experiments with flavin monooxygenases were inconclusive, those with 
recombinant cytochrome P450s (CYPs) strongly suggested that CYP2B6 was the principle 
enzyme responsible for TATP hydroxylation. TATP-O-glucuronide was also identified and 
incubations with recombinant uridine diphosphoglucuronosyltransferases (UGTs) 
indicated that UGT2B7 catalyzes this reaction. Michaelis–Menten kinetics were 
determined for TATP hydroxylation, with Km = 1.4 µM and Vmax = 8.7 nmol/min/nmol 
CYP2B6. TATP-O-glucuronide was present in the urine of all three volunteers after being 
exposed to TATP vapors showing good in vivo correlation to in vitro data. TATP and 
TATP-OH were not observed. 
Conclusions Since scientists working to characterize and detect TATP to prevent terrorist 
attacks are constantly exposed to this volatile compound, attention should be paid to its 
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Triacetone triperoxide (3,3,6,6,9,9-hexamethyl-1,2,4,5,7,8-hexoxonane, TATP) is 
a homemade explosive, easily synthesized from household items [1]. For this reason, TATP 
has often been used by terrorists [2, 3], necessitating its research by bomb squad, canine 
(K9) units, and scientists [4]. In addition to being extremely hazardous, this peroxide 
explosive is highly volatile, with partial pressure of 4-7 Pa at 20 °C [5, 6]. Personnel 
exposed to TATP will most likely absorb it through inhalation and/or dermal absorption. 
However, no information on the human absorption, distribution, metabolism, excretion and 
toxicity (ADMET) of TATP is available. Therefore, this paper will investigate the in vitro 
metabolism of TATP and the in vivo excretion through urine analysis. 
The toxicity of most military explosives has been well characterized [7]. The 
biotransformation of trinitrotoluene, for example, has been thoroughly investigated. It is 
metabolized by cytochrome P450 (CYP) reductase, forming nitroso intermediates, and 
yielding 4-hydroxylamino-2,6-dinitrotoluene, 4-amino-2,6-dinitrotoluene and 2-amino-
4,6-dinitrotoluene. These primary metabolites are further reduced by CYP to 2,4-diamino-
6-nitrotoluene and 2,6-diamino-4-nitrotoluene [8, 9]. In vivo studies of Chinese 
ammunition factory workers found metabolites such as 4-amino-2,6-dinitrotoluene and 2-
amino-4,6-dinitrotoluene, in urine and bound to the hemoglobin in blood [9, 10]. TATP 
has been studied for almost two decades, but its metabolism and toxicity are still unknown. 
TATP characterization is problematic since it is an extremely sensitive explosive, difficult 





Most xenobiotics are metabolized by CYP which is a family of heme-containing enzymes 
found in all tissues, particularly the liver endoplasmic reticulum (microsomes). CYPs 
catalyze phase I oxidative reactions (among others) in the presence of oxygen and a 
reducing agent (usually reduced nicotinamide adenine dinucleotide phosphate, NADPH). 
NADPH provides electrons to the CYP heme via CYP reductase. This oxidation generally 
produces more polar metabolites that are either excreted in the urine or undergo phase II 
biotransformation, further increasing their hydrophilicity [11]. One of the most common 
phase II reactions is glucuronidation, which is catalyzed by uridine 
diphosphoglucuronosyltransferase (UGT) in the presence of the cofactor uridine 
diphosphoglucuronic acid (UDPGA). In this reaction, glucuronic acid is conjugated onto 
an electron-rich nucleophilic heteroatom, frequently added to the substrate by phase I 
metabolism. Glucuronide metabolites increase the topological polar surface area (TPSA) 
and reduce the partition coefficient (LogP) of xenobiotics to be ionized at physiological 
pH, thus, increasing the aqueous solubility of the compound for excretion [11]. 
TATP is a cyclic peroxide, a motif shared with the antimalarial drug, artemisinin. 
The endoperoxide functionality of artemisinin is thought to be crucial for its antimalarial 
activity [12]. In the presence of ferrous ions, artemisinin undergoes homolytic peroxide 
cleavage to yield an oxygen radical that may be lethal to malaria parasite, Plasmodium 
falciparum. Biotransformation studies indicate that artemisinin is primarily metabolized by 
CYP2B6 to deoxyartemisinin, deoxydihydroartemisinin, dihydroartemisinin and ‘crystal-
7’ [13, 14]. Similarly, we have previously shown that TATP is metabolized in vitro by 





metabolized by glucuronidation, particularly by UGT1A9 and UGT2B7, to 
dihydroartemisinin-glucuronide, the principal metabolite found in urine, suggesting 
endoperoxides, like TATP, may be glucuronidated and excreted in urine [16]. 
Laboratory personnel who work on synthesizing, characterizing and detecting 
TATP are inevitably exposed to this volatile compound. Even the small-sized samples that 
they work with can result in buildup of TATP in a confined space. Furthermore, bomb-
sniffing dogs and their handlers are purposely exposed to these vapors for the sake of 
training. Our previous study revealed TATP metabolism in dog liver microsomes (DLM) 
[15]. Now we evaluate its in vitro biotransformation in human liver microsomes (HLM) 
and recombinant enzymes, identifying phase I and phase II metabolites, estimating enzyme 
kinetics and also detecting urinary in vivo metabolites excreted from scientists exposed to 






Materials and Methods 
Chemicals 
Optima HPLC grade methanol, Optima HPLC grade water, Optima HPLC grade 
acetonitrile, American Chemical Society (ACS) grade acetone, ACS grade methanol, ACS 
grade pentane, hydrochloric acid, ammonium acetate, dipotassium phosphate, 
monopotassium phosphate, magnesium chloride (MgCl2) and reduced glutathione (GSH) 
were purchased from Fisher Chemical (Fair Lawn, NJ, USA); NADPH, 1-
aminobenzotriazole, methimazole, 1-naphthol and hydroxyacetone from Acros Organics 
(Morris Plain, NJ, USA); UDPGA, saccharolactone and 2,4-dichlorophenoxyacetic acid 
from Sigma-Aldrich (St. Louis, MO, USA); bupropion, benzydamine and alamethicin from 
Alfa Aesar (Ward Hill, MA, USA); oxcarbazepine from European Pharmacopoeia 
Reference Standard (Strasbourg, France); ticlopidine from Tokyo Chemical Industry 
(Tokyo, Japan); hydroxybupropion from Cerilliant Corporation (Round Rock, Texas, 
USA); deuterated acetone (acetone-d6) from Cambridge Isotope Labs (Cambridge, MA, 
USA); hydrogen peroxide (50%) from Univar (Redmond, WA, USA); HLM, rat liver 
microsomes (RLM), DLM and human lung microsomes (HLungM) from Sekisui 
XenoTech (Kansas City, KS, USA); human recombinant CYP (rCYP) bactosomes 
expressed in Escherichia coli (E. coli) from Cypex (Dundee, Scotland); human 
recombinant flavin monooxygenase (rFMO) supersomes and human recombinant UGT 







TATP, deuterated TATP (TATP-d18) and hydroxy-TATP (TATP-OH) synthesis 
TATP was synthesized following the literature methods using hydrochloric acid as 
the catalyst [1]. TATP was purified by recrystallization, first with methanol/water (80:20, 
w/w) and then with pentane. TATP-d18 was synthesized as above using acetone-d6. TATP-
OH was synthesized as above using hydrogen peroxide (50 wt%)/acetone/hydroxyacetone 
(2:1:1, mol ratio) [15]. TATP-OH was purified using a CombiFlash RF+ system with an 
attached PurIon S MS system (Teledyne Isco, Lincoln, NE, USA), followed by two cycles 
of drying and reconstituting in solvent to sublime away the TATP. Separation was 
performed using a C-18 cartridge combined with a liquid chromatograph flow of 18 
mL/min with 10% methanol (A) and 90% aqueous 10 mM ammonium acetate (B) for 1 
min, before ramping to 35%A/65%B over 1 min, followed by another ramp to 95%A/5%B 
over the next 1 min, holding for 2 min, before a 30 s transition to initial conditions, with a 
hold of 2 min [15]. 
 
Instrumental analyses 
Metabolite identification was performed by high‐performance liquid 
chromatography coupled to Thermo Scientific Exactive or Thermo Scientific LTQ 
Orbitrap XL high resolution mass spectrometers (HPLC–HRMS) (Thermo Fisher 
Scientific, Waltham, MA, USA). A CTC Analytics PAL autosampler (CTC Analytics, 
Zwinger, Switzerland) was used for LC injections, solvent delivery was performed using a 
Thermo Scientific Accela 1200 quaternary pump, and data collection/analysis was done 





Metabolite quantification was performed by high‐performance liquid 
chromatography coupled to AB Sciex Q-Trap 5500 triple quadrupole mass spectrometer 
(HPLC–MS/MS) (AB Sciex, Toronto, Canada). A CTC Analytics PAL autosampler was 
used for LC injections, solvent delivery was performed using a Thermo Scientific Accela 
1200 quaternary pump and data collection/analysis was done with Analyst software (AB 
Sciex, version 1.6.2).  
The HPLC method for all TATP derivatives was as follows: sample of 40 µL 
(Exactive and LTQ Orbitrap XL) or 20 µL (Q-Trap 5500) in acetonitrile/water (50:50, v/v) 
were injected into LC flow at 250 µL/min of 10%A/90%B for introduction onto a Thermo 
Syncronis C18 column (50 × 2.1 mm i.d., particle size 5 µm). Initial conditions were held 
for 1 min before ramping to 35%A/65%B over 1 min, followed by another ramp to 
95%A/5%B over the next 1 min. This ratio was held for 2 min before reverting to initial 
conditions over 30 s, which was held for additional 2 min. The Exactive MS tune conditions 
for atmospheric pressure chemical ionization (APCI) in positive mode were as follows: N2 
sheath gas flow rate, 30 arbitrary units (AU); N2 auxiliary gas flow rate, 30 AU; discharge 
current, 6 µA; capillary temperature, 220 °C; capillary voltage, 25 V; tube lens voltage, 40 
V; skimmer voltage, 14 V; and vaporizer temperature, 220 °C. The Exactive MS tune 
conditions for electrospray ionization (ESI) in negative mode were as follows: N2 sheath 
gas flow rate, 30 AU; N2 auxiliary gas flow rate, 15 AU; spray voltage, -3.4 kV; capillary 
temperature, 275 °C; capillary voltage, -35 V; tube lens voltage, -150 V; and skimmer 
voltage, -22 V. The LTQ Orbitrap XL MS tune conditions for ESI–, used for TATP-O-





flow rate, 15 AU; spray voltage, -4 kV; capillary temperature, 275 °C; capillary voltage, -
15 V; and tube lens voltage, -84 V. The single-reaction monitoring settings were as follows: 
m/z 413.13 with isolation width m/z 1.7, activated by higher-energy collision dissociation 
at 35 eV. The Q-trap 5500 MS tune and multiple reaction monitoring (MRM) conditions 
are shown in Table 2-1. TATP and TATP-OH quantification was done as the area ratio to 
TATP-d18 (internal standard, IS) using a standard curve ranging 10-20,000ng/mL and 10-
500 (Figure B-1) or 500-8,000 ng/mL, respectively. TATP-O-glucuronide relative 
quantification was done as the area ratio to 2,4-dichlorophenoxyacetic acid (IS). 
The HPLC method for bupropion, hydroxybupropion, benzydamine, benzydamine 
N-oxide, and oxcarbazepine (IS), was as follows: sample of 10 μL in acetonitrile/water 
(50:50, v/v) were injected into LC flow at 250 μL/min with 30%A/70%B for introduction 
onto a Thermo Scientific Acclaim Polar Advantage II C18 column (50 × 2.1 mm i.d., 
particle size 3 µm). Initial conditions were held for 1 min before instant increase to 
95%A/5%B, held for 2.5 min, and then reversed to initial conditions over 30 s, with a hold 
of 1 min for the bupropion, hydroxybupropion and oxcarbazepine method or with a hold 












Table 2-1. Triple quadrupole mass spectrometer (Q-trap 5500) operating parameters 
Parameters  Method 1  Method 2  Method 3 
Source type  APCI+  ESI–  ESI+ 
Source temperature °(C)  300  300  260 
Ion spray voltage (V)  N/A  -4500  4500 
Nebulizer current (µA)  0.8  N/A  N/A 
Ion source gas 1 (psi)  50  50  20 
Ion source gas 2 (psi)  2  2  2 
Curtain gas (psi)  28  28  30 
Collision gas (psi)  6  6  5 
Declustering potential (V)  26  -26  30 
Entrance potential (V)  10  -10  10 
Internal standard MRM 
transitions (m/z) 
 
258 → 80, 46 
 
219 → 161, 125 
 
253 → 208, 180 
Collision energy (V)  11, 27  -13, -27  27, 39 








Analyte  TATP TATP-OH  TATP-O-gluc  BUP BUP-OH BZD BZD-NO 
Analyte MRM transition 
(m/z) 
 240 → 
74, 43 
256 →   75 
 413 →          113, 
87 






326 →  
102 
Collision energy (V)  11, 28 13  -22, -34  17, 23 15, 33 21 19 
Collision cell exit 
potential (V) 
 




20, 10 12, 16 10 12 
APCI+ positive mode atmospheric pressure chemical ionization, BUP bupropion, BUP-OH hydroxybupropion, BZD benzydamine, 
BZD-NO benzydamine N-oxide, ESI+ positive mode electrospray ionization, ESI– negative mode electrospray ionization, MRM multiple 







All incubations were performed in triplicates in a Thermo Scientific Digital Heating 
Shaking Drybath set to body temperature 37 °C and 800 rpm. An incubation mixture 
containing phosphate buffer (pH 7.4), MgCl2 [17], and NADPH (CYP cofactor [11]) was 
prepared so that at a final volume of 1 mL, their concentrations were 10, 2 and 1 mM, 
respectively. When the incubation times were relatively long (greater than 15 min), it was 
thought necessary to use closed vessels to avoid loss of the volatile TATP or TATP-OH; 
as a result, prior to incubation, oxygen gas was bubbled through the buffer to ensure ample 
oxygen availability [15]. To this mixture, microsomes or recombinant enzymes were added 
and equilibrated for 3 min before the reaction was initiated by adding the substrate. 
Substrates included TATP in acetonitrile, TATP-OH in methanol, and bupropion and 
benzydamine in water. Organic solvents can disrupt metabolism, but the catalytic activity 
of most CYP enzymes is unaffected by less than 1% acetonitrile or methanol [18]. At the 
end point, an aliquot was transferred to a vial containing equal volume of ice-cold 
acetonitrile and immediately vortex-mixed to quench the reaction. The sample was 
centrifuged for 5 min at 14,000 rpm, and the supernatant was analyzed by LC–MS. 
 Metabolite identification studies used microsomes (HLM, RLM and DLM) at 
protein concentrations of 1 mg/mL in the incubation mixture. The substrate, TATP, TATP-
OH, or TATP -d18 (10 µg/mL) was allowed to incubate for several min before MS analysis. 
Negative controls consisted of the incubation mixture excluding either microsomes or 





Phase II TATP metabolism was examined by two studies. Metabolism by glutathione S-
transferase (GST) was probed by equilibrating 5 mM GSH (GST cofactor [11]) for 5 min 
in the incubation mixture including HLM before the substrate (TATP) was added. 
Ticlopidine (10 µM) was the substrate for the GST positive control (Figure B-2) [22]. To 
examine metabolism by UGT, HLM, buffer, and alamethicin (50 µg/mL in 
methanol/water) were equilibrate cold for 15 min, before saccharolactone (1 mg/mL, β-
glucuronidase inhibitor [23]), MgCl2, and NADPH were added, and the mixture was 
warmed to 37 °C and shaken at 800 rpm. After 3 min equilibration, the substrate (TATP or 
TATP-OH) was added, and in 2 min, the reaction was started by the addition of 5.5 mM 
UDPGA (UGT cofactor [11]) [24, 25]. Positive control used 100 µM 1-naphthol, an 
UGT1A6 substrate (Figure B-3) [26, 27]. Alamethicin was employed to replace membrane 
transporters, in allowing UGT (located in the endoplasmic reticulum lumen) easy access to 
the UDPGA cofactor [11]. 
 
Enzyme identification 
TATP was incubated as described in the previous section with various enzyme 
inhibitors in HLM (1 mg/mL). TATP-OH formation was first monitored and benchmarked 
against incubations without inhibitors. Chemical inhibitors, such as 1-aminobenzotriazole 
(1 mM) [28, 29], methimazole (500 µM) [30, 31], or ticlopidine (100 µM) [32, 33], were 
pre-equilibrated in the incubation mixture for 30 min prior to the addition of the substrate 
(100 µM, TATP or controls). TATP was also tested as a possible CYP2B6 inhibitor; TATP 





with a known CYP2B6 substrate (bupropion) or TATP, respectively. FMO inhibition by 
heat was also tested [11, 34]. In that experiment, HLM was mixed with buffer and pre-
heated at 37 or 45 °C for 5 min. After an hour, cooling on ice, the incubation procedure 
was resumed. Bupropion, a CYP2B6 substrate [19–21], and benzydamine, an FMO 
substrate [34], were used as positive and negative control substrates to assess CYP, FMO 
and CYP2B6 inhibition. Samples not pre-incubated with chemical inhibitors nor heated to 
45 °C were used as 100% TATP-OH formation. Inhibition studies were quenched after 15 
min incubation. 
Recombinant CYP and FMO enzymes were employed to identify the isoform 
responsible for the NADPH-dependent metabolism. Human bactosomes expressed in E. 
coli were used for CYP isoform identification; CYP1A2, CYP2B6, CYP2C9, CYP2C19, 
CYP2D6, CYP2E1 and CYP3A4 (100 pmol CYP/mL) were tested. Human supersomes 
expressed in insect cells were used for FMO isoform identification; FMO1, FMO3 and 
FMO5 (100 µg protein/mL) were examined. Both TATP and TATP-OH were tested as the 
substrate (10 µg/mL) in the incubation mixture with the recombinant enzymes. Negative 
control incubations were done in E. coli control or insect cell control. Positive control 
incubations were done in HLM (200 pmol CYP/mL), which contains all CYP and FMO 
enzymes. Recombinant enzymes studies were quenched after 10 min incubation. 
Recombinant UGT enzymes were used to identify the isoform responsible for phase 
II metabolism. Human supersomes expressed in insect cells were used for UGT isoform 
identification; UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9 and UGT2B7 were 





previously described, except saccharolactone was not added [35]; 500 µg protein/mL was 
used; and the substrate was 10 µg/mL TATP-OH. Negative control incubations were done 
in insect cell control. Positive control incubations were done in HLM (1 mg protein/mL), 
which contains all UGT enzymes. Glucuronidation with recombinant enzymes was 
quenched after 2 h incubation. 
 
Enzyme kinetics 
Kinetics experiments were done to determine the affinity of the enzyme CYP2B6 
to the substrate TATP. The human CYP2B6 bactosomes used contained human CYP2B6 
and human CYP reductase co-expressed in E. coli, supplemented with purified human 
cytochrome b5. CYP reductase is responsible for the transfer of electrons from NADPH to 
CYP, a task sometimes extended to cytochrome b5 [11]. The incubation mixture (1 mL) 
contained 10 mM phosphate buffer (pH 7.4), 2 mM MgCl2, 50 pmol/mL rCYP2B6, 1 mM 
NADPH, and various concentrations of 0.1 to 20 µM TATP. The reaction was initiated by 
adding TATP after a 3 min pre-equilibration and stopped at different end points (up to 5 
min) to determine rate of TATP hydroxylation. The rate of TATP hydroxylation in lungs 
was also investigated by incubating TATP (100 µM) in the incubation mixture containing 
1 mg/mL HLM or HLungM, instead of rCYP2B6, for up to 10 min. 
TATP-OH metabolism by CYP2B6 was evaluated by incubating 10 µg/mL TATP-
OH in CYP2B6 bactosomes according to the above procedure, with or without NADPH, 
except that the buffer was pre-oxygenated so that the incubation could be performed in a 





TATP-OH depletion by HLM was determined using the same procedure, except that 1 µM 
TATP-OH and up to 60 min reaction times were used. 
 
Urine analysis 
Laboratory personnel testing TATP are constantly exposed to this volatile 
compound. Explosive sensitivity experiments, such as drop weight impact tests, are done 
in a small brick-walled room for explosivity precautions, unlike synthesis reactions which 
are performed inside a fume hood for coverage protection. Also, portable explosive trace 
detection devices that are meant to be used in the field are tested as such, which also 
contribute to exposure. Urine from laboratory workers was tested for TATP and its 
metabolites after TATP exposure in the laboratory environment. Urine was collected at the 
beginning of the work week and 2 h after performing activities that could lead to high 
TATP exposure. To determine the longevity of TATP in the body, urine from the day 
following TATP exposure was also tested. The fresh urine was cleaned and concentrated 
for analysis using solid-phase extraction. Restek RDX column (Restek, Bellefonte, PA, 
USA) was conditioned with 6 mL of methanol, followed by 6 mL of water, and sample 
introduction (20-250 mL urine). The sample was washed with two cycles of 3 mL 
methanol/water (50:50, v/v). Extraction was achieved with two cycles of 1 mL acetonitrile. 
Both eluents were tested by LC–MS, because the lipophilic TATP and TATP-OH were 








When TATP was incubated in HLM, TATP was depleted, and one observable 
product, TATP-OH, was formed over time (Figure 2-1). Metabolism of TATP in HLM 
consists of hydroxylation at one methyl group with the peroxide bonds and nine-membered 
ring structure preserved (Figure 2-2) [15]. Opsenica and Solaja [12] reported various 
monohydroxylated and dihydroxylated products during microsomal incubations with 
cyclohexylidene and steroidal mixed tetraoxanes where the peroxide bond was also 
preserved. A TATP-OH standard (Figure B-4) was chemically synthesized to confirm the 
metabolite by retention time and mass-to-charge ratio (m/z). TATP-OH, identified as 
[TATP-OH + NH4]
+ (m/z 256.1391) by accurate mass spectrometry, increased in 
incubation samples as time progressed. Attempts to confirm the hydroxylated metabolite 
with the deuterated substrate were unsuccessful due to the persistence of a contaminant 
with the same mass that the metabolite would have had, even in samples where TATP-d18 
was not used as the substrate. As previously observed, TATP incubations in different 
species (dogs and rats) yielded the same metabolite, TATP-OH (Figure B-5) [15]. Other 
suspected metabolites, including the dihydroxy-species and additional oxidation of the 
TATP-OH to the aldehyde and carboxylic acid were not observed. Small polar molecules, 
such as acetone and hydrogen peroxide, the synthetic reagents of TATP, could not be 







Figure 2-1. Triacetone triperoxide (TATP) biotransformation into hydroxy-TATP (TATP-














TATP was investigated for phase II metabolism routes of glutathione and 
glucuronide conjugation. Incubation in HLM with GSH produced no detectable glutathione 
metabolite conjugates, indicating that TATP is most likely not a substrate for microsomal 
GSTs (Figure B-6). When TATP was incubated with UDPGA, the TATP-OH glucuronic 
acid metabolite (TATP-O-glucuronide) was observed (Figure 2-2). The m/z 432.1712 for 
[TATP-O-glucuronide + NH4]
+ was observed at very low levels after 2 and 3 h of 
incubation. When the sample was dried and reconstituted in low volume, the intensity of 
[TATP-O-glucuronide + NH4]
+ increased, but TATP and TATP-OH were evaporated along 
with the solvent. TATP and TATP-OH are volatile, limiting their use in quantification 
experiments since sample concentration is not feasible [5]. However, TATP-O-glucuronide 
is a non-volatile TATP derivative that is amenable to sample preparation. Formation of 
TATP-O-glucuronide over time was monitored, using concentrated samples, as an intensity 
increase of m/z 432.1712 (Figure B-7). Even though TATP and TATP-OH generally form 
ammonia adducts under positive ion APCI, the glucuronide favors negative ion mode ESI. 
The m/z 413.1301 for [TATP-O-glucuronide – H]- was easily seen at 1-3 h without sample 
concentration. The common fragments of glucuronic acid, m/z 175, 113, and 85, were 
observed in the fragmentation pattern of m/z 413.1301, confirming the presence of a 
glucuronic acid conjugate (Figure 2-3) [36]. TATP-O-glucuronide was not observed in 
negative controls without UDPGA or NADPH, indicating that TATP-OH must be formed 
and then be further metabolized into TATP-O-glucuronide. Glucuronide conjugates are 
highly polar compounds that are easily eliminated by the kidney, suggesting that TATP-









Figure 2-3. Product ion spectrum of [TATP-O-glucuronide – H]- (m/z 413.1301), fragmented with 35 eV using electrospray ionization 






TATP was only metabolized into TATP-OH in HLM in the presence of NADPH, 
indicating that the metabolism is NADPH-dependent. The predominant microsomal 
enzymes that require NADPH for activity are CYP and FMO [11]. 
The usual roles of CYP are hydroxylation of an aliphatic or aromatic carbons, 
epoxidation of double bonds, heteroatom oxygenation or dealkylation, oxidative group 
transfer, cleavage of esters and dehydrogenation reactions [11]. 1-Aminobenzotriazole is 
considered a general mechanism-based inhibitor of CYPs, initiated by metabolism into 
benzyne, which irreversibly reacts with the CYP heme [28, 29]. When CYP activity was 
inhibited by 1-aminobenzotriazole, TATP-OH formation was also inhibited, with only 
3.6% formed (Table 2-2), suggesting that CYP is involved in the hydroxylation of TATP. 
To support this evidence and to narrow down the CYP isoform catalyzing TATP 
hydroxylation, TATP was incubated with rCYPs (Figure 2-4, Table B-1). The CYPs 
selected for testing are responsible for the metabolism of 89% of common xenobiotics [37]. 
TATP-OH was not observed when TATP was incubated with CYP1A2, CYP2C9, 
CYP2C19, CYP2D6, CYP2E1 and CYP3A4. TATP hydroxylation was performed 
exclusively by CYP2B6, with 5.6 ± 0.3 µM TATP-OH produced in 10 min. CYP2B6 has 
been found to metabolize endoperoxides by hydroxylation, as observed for TATP [13, 14]. 













 Percent found 
 Inhibitor pre-incubated in HLM for 30 min 





1-ABT MMI TIC 
TATP or 
BUP 
 37°C 45°C 
TATP-OH (%)  100 ± 5 3.6 ± 0.7 34 ± 2 4.8 ± 0.7 125 ± 21  100 ± 10 69 ± 4 
BUP-OH (%)  100 ± 3 23 ± 1 62 ± 2 9.6 ± 0.4 62 ± 2  100 ± 6 99 ± 2 
BZD-NO (%)  100 ± 2 97 ± 1 48 ± 1 98 ± 3 N/A  100 ± 2 44 ± 2 
1-ABT 1-aminobenzotriazole (CYP inhibitor), CYP cytochrome P450, FMO flavin monooxygenase, HLM human liver microsomes, 






Figure 2-4. TATP-OH formation from TATP incubations with recombinant cytochrome 
P450 (rCYP) and recombinant flavin monooxygenase (rFMO). Experiments with rCYP or 
rFMO consisted of 10 µg/mL TATP incubated with 10 mM phosphate buffer (pH 7.4), 2 
mM MgCl2 and 1 mM reduced nicotinamide adenine dinucleotide phosphate (NADPH). 






Since DLM studies indicated that TATP is metabolized by CYP2B11 [15], it was 
not surprising that another CYP2B subfamily enzyme, CYP2B6, metabolizes TATP in 
humans. CYP2B6 metabolism of TATP was further investigated by incubating TATP with 
ticlopidine, a mechanism-based inhibitor of CYP2B6 [32, 33]. When CYP2B6 activity was 
inhibited by ticlopidine, TATP-OH formation was also inhibited by 95% (Table 2-2), 
further supporting the primary involvement of CYP2B6 in the metabolism of TATP. 
Bupropion hydroxylation is catalyzed by CYP2B6; therefore, it was chosen as a positive 
control for CYP and CYP2B6 inhibition tests [28]. Hydroxybupropion formation was 
inhibited by 77 and 90% when incubated with 1-aminobenzotriazole and ticlopidine, 
respectively (Table 2-2). 
FMO catalyzes oxygenation of nucleophilic heteroatoms, such as nitrogen, sulfur, 
phosphorous and selenium [34, 38]. Although FMO involvement in the hydroxylation of 
the TATP methyl group was unlikely, it seemed prudent to examine this enzyme class. 
Addition of methimazole, an FMO competitive inhibitor [30, 31], caused a decrease in 
TATP-OH formation by 66% (Table 2-2), but this is not necessarily direct inhibition of 
TATP metabolism by FMO since methimazole has been reported to reduce CYP2B6 
activity by up to 80% [34, 39]. While this result was inconclusive about the FMO 
contributions to TATP metabolism, it could be considered further support for the role of 
CYP2B6. TATP was incubated with available rFMOs: FMO1, FMO3 and FMO5 (Figure 
2-4, Table B-1). FMO1 is expressed in adults in the kidneys, and it should not contribute 
to the liver metabolism of TATP [34]; indeed, none appeared to be involved as no TATP-





34], TATP was incubated in HLM pre-heated to 45 °C for 5 min. Table 2-2 compares the 
formation of TATP-OH at 37 °C to that at 45 °C and to the N-oxidation of the positive 
control, benzydamine. Although, there was a decrease in TATP hydroxylation, the 
inhibitory effect was not as significant as compared to the decrease in benzydamine N-
oxidation, which is catalyzed by FMO.  
TATP-OH appears to be metabolized by HLM in an NADPH-dependent manner; 
therefore, TATP-OH was incubated for 10 min with recombinant enzymes (CYP and 
FMO) to determine which isoform is responsible for this secondary phase I metabolism 
(Table 2-3). Although TATP-OH is not nearly as volatile as TATP, some TATP-OH was 
lost in all incubations (i.e., 37 oC); however, notable depletion (by 40%) was observed only 
with CYP2B6. TATP-OH depletion in CYP2B6 was faster in the presence of NADPH than 
in its absence, supporting metabolism by CYP2B6 (Figure B-9). Unfortunately, no 












HLM 69 ± 5 
rCYP control 76 ± 4 
rCYP1A2 77 ± 2 
rCYP2B6 60 ± 3 
rCYP2C9 71 ± 8 
rCYP2C19 76 ± 5 
rCYP2D6 76 ± 5 
rCYP2E1 73 ± 5 
rCYP3A4 78 ± 6 
rFMO control 69 ± 3 
rFMO1 78 ± 12 
rFMO3 78 ± 6 
rFMO5 72 ± 7 








To identify which isoform is responsible for TATP glucuronidation, TATP-OH was 
incubated with the most clinically relevant rUGTs (Figure 2-5, Table B-2) [40]. 
Glucuronidation was not observed with UGT1A1, UGT1A3, UGT1A4, UGT1A6 and 
UGT1A9. TATP-O-glucuronide was formed only in UGT2B7 incubations with 0.05 ± 0.03 
area count relative to IS produced after 2 h of incubation. HLM, which contains UGT2B7, 
also displayed TATP-O-glucuronide (0.26 ± 0.02 area count relative to IS). Relative 
quantification of TATP-O-glucuronide was done by area ratio to the IS because a TATP-
O-glucuronide standard is not available. Endoperoxide glucuronidation by UGT2B7 has 
been reported, in which urine analysis of patients treated with artesunate, an artemisinin 








Figure 2-5. TATP-O-glucuronide formation from TATP-OH incubations with 
recombinant uridine diphosphoglucuronosyltransferase (rUGT). Experiments with rUGT 
consisted of 10 µg/mL TATP-OH incubated with 10 mM phosphate buffer (pH 7.4), 2 mM 
MgCl2, 50 µg/mL alamethicin, 1 mM NADPH, and 5.5 mM uridine diphosphoglucuronic 
acid (UDPGA). Glucuronidation done in triplicate and quenched at 2 h. Quantification was 








Rate of TATP hydroxylation by CYP2B6 was evaluated by plotting concentration 
of TATP-OH formed over time. The initial rate of TATP hydroxylation at various TATP 
concentrations was used to estimate enzyme kinetics using the Michaelis–Menten model: 
v = Vmax × [S] / (Km + [S]). Here, [S] is the substrate (TATP) concentration, Vmax is the 
maximum formation rate, Km is the substrate concentration at half of Vmax, and kcat is the 
turnover rate of an enzyme-substrate complex to product and enzyme [41]. The kinetic 
constants were obtained using nonlinear regression analysis on GraphPad Prism software 
(version 8.2.1). The Michaelis–Menten evaluation for TATP hydroxylation by CYP2B6 
(Figure 2-6) yielded Km of 1.4 µM; Vmax of 8.7 nmol/min/nmol CYP2B6; and kcat of 174 
min-1. Linearized models, such as Lineweaver–Burk (Figure B-10), Eadie–Hofstee 







Figure 2-6. Rate of TATP hydroxylation by CYP2B6 versus TATP concentration. 
Incubations of various TATP concentrations consisted of 50 pmol rCYP2B6/mL with 10 
mM phosphate buffer (pH 7.4), 2 mM MgCl2 and 1 mM NADPH. Incubations were done 






The low Km indicates TATP has a high affinity for CYP2B6 [42]. Table 2-2 shows 
that TATP inhibits bupropion hydroxylation by CYP2B6, with only 62% 
hydroxybupropion formation in 15 min. However, in the presence of bupropion, TATP-
OH formation was enhanced, with 125% formed compared to the reaction uninhibited by 
bupropion (Table 2-2). CYP2B6 preference for TATP affects the metabolism of 
bupropion, but further testing is needed to establish the specific type of inhibition.  
Using the Michaelis–Menten parameters, in vitro intrinsic clearance (Clint = Vmax / 
Km) was calculated to be 6.13 mL/min/nmol CYP2B6 [11, 43, 44]. Scale-up of the Clint to 
yield intrinsic clearance on a per kilogram body weight was done using values of 0.088 
nmol CYP2B6/mg microsomal protein, 45 mg microsomal protein/g liver wet weight and 
20 g liver wet weight/kg human body weight [43]. Taking that into account, the scale-up 
Clint was calculated to be 485 mL/min/kg.  
In vivo intrinsic clearance (Cl) is the ability of the liver to metabolize and remove 
a xenobiotic, assuming normal hepatic blood flow (Q = 21 mL/min/kg [43, 45]) and no 
protein binding [43]. Cl can be extrapolated using the well-stirred model excluding all 
protein binding as Cl = Q × Clint / Q + Clint [43]. The in vivo intrinsic clearance of TATP 
was estimated as 20 mL/min/kg. Compared to common drugs, TATP has a moderate 
clearance [46]. 
TATP-OH kinetics were also investigated by substrate depletion. Substrate 
depletion was plotted as the natural log of substrate percent remaining over time (Figure 
2-7). Half-life (t1/2) was calculated to be 16 min, as the natural log 2 divided by the negative 





(0.693 / t1/2) × (incubation volume / mg microsomal protein) [47, 48]. The in vitro intrinsic 
clearance of TATP-OH was estimated as 0.042 mL/min/mg. Even though we identified 







Figure 2-7. Natural log of TATP-OH percent remaining in HLM versus time. TATP-OH 
(1 µM) incubated in 1 mg/mL HLM with pre-oxygenated 10 mM phosphate buffer (pH 
7.4), 2 mM MgCl2 and 1 mM NADPH. Incubations were done in closed vials, in triplicate 







Inhalation is the most probable pathway for systemic exposure since TATP is both 
volatile and lipophilic. With passive diffusion into the bloodstream being very possible, 
TATP metabolism in the lung was also investigated. TATP was incubated in lung and liver 
microsomes for comparison of metabolic rate. The results, shown in Table 2-4, indicated 
that TATP hydroxylation in the lungs was negligible. Though CYP2B6 gene and protein 
are expressed in the lungs, enzyme activity in lungs is minimal as compared to the liver, 
limiting TATP metabolism [49, 50]. This suggests that TATP is most likely distributed 
through the blood to the liver for metabolism. News reported that traces of TATP was 
found in the blood samples extracted from the 2016 Brussels suicide bombers [51]. This 






Table 2-4. Rate of TATP hydroxylation (triplicates) in human liver microsomes versus 
human lung microsomes 
Human 
microsomes 
Rate of TATP-OH 
formation (nmol/min/mg) 
Liver 0.425 ± 0.06 
Lung lot1710142 < LOQ 
Lung lot1410246 < LOQ 








In vivo human urine analysis 
Laboratory workers, who normally work with TATP on a daily basis, performing 
tasks like explosive sensitivity testing, were screened for TATP exposure. These laboratory 
workers volunteered to collect their urine before and after exposure to TATP vapor. Since 
the health effects of TATP exposure are unknown, to minimize any additional risks to these 
workers, this pilot study was performed in duplicates using only three volunteers to 
establish some reproducibility. TATP and TATP-OH were not observed in the urine of any 
of the workers. However, TATP-O-glucuronide was present in all urine samples collected 
2 h after TATP exposure (Figure 2-8). Two out of the three volunteers still showed TATP-
O-glucuronide in the urine collected the next day (Table 2-5). TATP-O-glucuronide was 
identified in human urine samples as both [TATP-O-glucuronide – H]- and [TATP-O-
glucuronide + NH4]
+. The presence of TATP-O-glucuronide in the urine of all three 







Figure 2-8. Extracted ion chromatogram of [TATP-O-glucuronide – H]- (m/z 413.1301) 
in HLM 2 h after incubation with TATP, and in human urine, before TATP exposure and 





Table 2-5. Summary of TATP-O-glucuronide presence in human urine (duplicates) in vivo 
Human 
m/z 413.1301  m/z 432.1712 
#1 #2 #3  #1 #2 #3 
Before TATP exposure - - -  - - - 
Two hours after TATP exposure + + +  + + + 
One day after TATP exposure + + -  + - - 
TATP glucuronide is observed as [TATP-O-glucuronide – H]- (m/z 413.1301) and [TATP-
O-glucuronide + NH4]











As described before, TATP is the explosive of choice by terrorists because it is 
easily synthesized from household items [1, 2]. In our previous study, we have clarified 
that TATP-OH is produced as an in vitro metabolite from TATP in dogs [15], because 
canines are currently one of the most reliable detection techniques used to find an explosive 
[52]. In the present article, the study has been conducted in continuation of our previous 
findings on both in vitro and in vivo metabolism of TATP in humans (Figure 2-2). 
Because TATP has high volatility, it is likely to be absorbed into the body by 
inhalation; however, no appreciable metabolism in the lung was observed in either dog [15] 
or human microsomes (Table 2-4). Therefore, systemic exposure and subsequent liver 
metabolic clearance was presumed. Across three species, dog, rat, and human, TATP was 
metabolized in liver microsomes by CYP to TATP-OH (Figure B-5). Using recombinant 
enzymes, we have previously established that CYP2B11 is responsible for this metabolism 
in dogs [15]. Interestingly, human CYP2B6 appears to be the major phase I enzyme 
responsible for the same metabolism (Figure 2-4). TATP hydroxylation by CYP2B6 
kinetics determined Km and Vmax as 1.4 µM and 8.7 nmol/min/nmol CYP2B6, respectively 
(Figure 2-6). Though heat inactivation and chemical inhibition of FMO appeared to affect 
TATP hydroxylation (Table 2-2), incubations with recombinant FMO suggest that FMO 
was not forming TATP-OH (Figure 2-4). Methimazole, an FMO inhibitor, inhibited 
TATP-OH formation (Table 2-2); but, inhibition of bupropion by this chemical inhibitor 





When incubated together, TATP and bupropion, appear to compete for CYP2B6 
metabolism, with bupropion hydroxylation being inhibited by 38% in the presence of 
TATP (Table 2-2). Considering CYP2B6 expression in the liver is low and exhibits broad 
genetic polymorphisms, CYP2B6 activity can be widely affected if TATP affects the 
metabolism of other compounds, like bupropion [53, 54]. TATP may be a serious 
perpetrator for drug-drug interactions for compounds cleared by CYP2B6 [55, 56]. 
In vitro clearance of TATP was calculated as 0.54 mL/min/mg protein with hepatic 
in vivo extrapolation to 20 mL/min/kg. In vitro clearance of TATP-OH was estimated, 
using substrate depletion, as 0.038 mL/min/mg protein (Figure 2-7). We also established 
the clearance of TATP in dogs as 0.36 mL/min/mg protein in our previous study in canine 
microsomes [15], which is significantly relevant to K9 units, where the dog and human 
handler are both exposed to the explosive. 
Investigation into the next step on the metabolic pathway indicated that TATP-OH 
is further metabolized by CYP2B6 (Table 2-3), but a secondary phase I metabolite was not 
identified. No glutathione adducts of any TATP metabolism products were observed in the 
microsomal incubations with GSH (Figure B-6). However, glucuronidation converted 
TATP-OH to TATP-O-glucuronide in HLM with UGT2B7 specifically catalyzing this 
reaction (Figure 2-5). Considering glucuronides are often observed as urinary metabolites, 
the presence of TATP-O-glucuronide in urine can be exploited as an absolute marker of 
exposure to TATP, which can be used as forensic evidence of TATP illegal use. 
Urine from scientists working to prevent terrorist attacks by synthesizing, 





were negatively tested for TATP and TATP-OH, but TATP-O-glucuronide was present at 
high levels in their fresh urine (Figure 2-8). In one out of the three volunteers, TATP-O-
glucuronide was not observed in the urine collected the day after TATP exposure (Table 
2-5), suggesting TATP to TATP-O-glucuronide in vivo clearance occurs within about a 
day depending on the exposure level. TATP-O-glucuronide presence in the urine of all 
three volunteers shows good in vivo correlation to in vitro data. 
Like TATP (hydrophilicity expressed as TPSA = 55.38 and lipophilicity expressed 
as cLogP =3.01, calculated using PerkinElmer ChemDraw Professional version 16.0.1.4), 
TATP-OH is lipophilic with TPSA and cLogP of 75.61 and 1.72, respectively. TATP-O-
glucuronide, on the other hand, is hydrophilic with TPSA and cLogP of 171.83 and 0.32, 
respectively. The increase in TPSA and decrease in cLogP from TATP to TATP-O-
glucuronide accounts for the glucuronide greater water solubility and facilitated excretion 
[11]; thus explaining the presence of only TATP-O-glucuronide in urine. 
Even though working with TATP falls under the protection of several standard 
operating procedures to handling explosives, considering the breathing exposure that these 
laboratory workers revealed, implementation of precautionary measures to absorption by 
inhalation, such as the use of respirators, should be considered. Such detection of TATP-
O-glucuronide is also useful for judicial authorities to raise a scientific evidence for 
exposure to TATP of terrorists and/or related individuals. 
This paper is the first to examine some aspects of TATP human ADMET, 
elucidating the exposure, metabolism and excretion of TATP in humans. However, the 






This article dealt with in vitro and in vivo studies of TATP metabolism in humans. 
TATP is highly volatile and easily introduced into human body via aspiration. By this 
study, TATP was found to be metabolized into TATP-OH by the action of CYP2B6, 
followed by glucuronidation of TATP-OH catalyzed by UGT2B7; the resulting TATP-O-
glucuronide was found to be excreted into urine in live humans. After extracting the TATP 
conjugate from urine specimens, it can be analyzed by HPLC–MS/MS, which gives 
scientific evidence for exposure to TATP. This evidence can be useful to prove exposure 
of persons, such as terrorists, to TATP for judicial authorities. Although this study includes 
the metabolism of TATP and also an analytical method to detect the TATP-O-glucuronide, 
the toxicology of TATP remains to be explored. 
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Mitigation of the peroxide explosive threat, specifically triacetone triperoxide 
(TATP) and hexamethylene triperoxide diamine (HMTD), is a priority among the law 
enforcement community, as scientists and canine (K9) units are constantly working to 
improve detection. We propose the use of paper spray ionization – high resolution mass 
spectrometry (PSI-HRMS) for detection of peroxide explosives in biological matrices. 
Occurrence of peroxide explosives and/or their metabolites in biological samples, obtained 
from urine or blood tests, give scientific evidence of peroxide explosives exposure. PSI-
HRMS promote analysis of samples in situ by eliminating laborious sample preparation 
steps. However, it increases matrix background issues, which were overcome by the 
formation of multiple alkali metal adducts with the peroxide explosives. Multiple ion 
formation increases confidence when identifying these peroxide explosives in direct 
sample analysis. Our previous work examined aspects of TATP metabolism. Herein, we 
investigate the excretion of a TATP glucuronide conjugate in the urine of bomb-sniffing 
dogs and demonstrate its detection using PSI from the in vivo sample. 
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Triacetone triperoxide (3,3,6,6,9,9-hexamethyl-1,2,4,5,7,8-hexoxonane, TATP) 
and hexamethylene triperoxide diamine (3,4,8,9,12,13-hexaoxa-1,6-
diazabicyclo[4.4.4]tetradecane, HMTD)  (Figure 3-1) are primary explosives, highly 
sensitive to initiation when exposed to friction, shock or static. TATP and HMTD are often 
called homemade explosives (HME) because they are easily synthesized from household 
items, an attractive feature to extremists that can legally procure their reagents when 
planning terrorist attacks [1–4]. To mitigate this threat, certain law enforcement specialists, 
e.g. bomb squads, and canine (K9) units, as well as scientists developing detection devices 
must be trained to recognize these peroxides [5]. However, there is no literature on the 
short or long term effects of TATP exposure in bomb-sniffing dogs.  
Knowledge of the absorption, distribution, metabolism, excretion and toxicity 
(ADMET) of peroxide explosives could be used to expand their detection capabilities. 
Once absorbed, chemical compounds are either excreted unchanged or are distributed to 
the liver for metabolism. In the liver, phase I oxidative reaction, usually catalyzed by 
cytochrome P450 (CYP), and/or phase II conjugation reactions, occasionally catalyzed by 
uridine diphosphoglucuronosyl-transferase (UGT) occur. These metabolic processes 
produce species that can be effectively excreted from the body [6]. Our previous work 
described the hepatic metabolism of TATP in humans in which TATP undergoes 
hydroxylation by CYP2B6 into TATP-OH, followed by glucuronidation into TATP-O-
glucuronide by UGT2B7 [7]. Even though the blood distribution of TATP to the liver was 





samples extracted from the 2016 Brussels suicide bombers [8]. Glucuronides often 
progress via urinary excretion [6], and this was supported by our findings that TATP-O-
glucuronide was present in the urine of laboratory personnel working with TATP [7]. 
Information about the blood distribution and urinary excretion of TATP can be used to 
develop blood and urine tests to be used as forensic evidence of TATP and/or HMTD 
exposure. 
TATP and HMTD are not detected by ultraviolet and fluorescence spectroscopy, 
techniques commonly used for toxicological assays; this precluded biological analysis [9, 
10]. Detection of these peroxide explosives relies heavily on infrared or Raman 
spectroscopy [11], gas or liquid chromatography mass spectrometry (MS) [5, 12], using 
laboratory-grade and field-portable devices. Airport security, for example, depends on 
trace techniques such as ion mobility spectrometry (IMS) and bomb-sniffing dogs [13, 14]. 
Currently, detection of compounds, such as explosives and drugs, from biological matrices 
requires exhaustive sample preparation including extraction, purification and 
chromatography before MS analysis [15, 16]. An analytical method is needed that allows 
rapid analysis, without sample preparation, with high selectivity to avoid false positives 
and high sensitivity to allow trace detection [14]. Ambient ionization techniques which 
allow generation of analyte ions directly from complex mixtures and require minimal 
sample preparation include desorption electrospray ionization (DESI) [17], direct analysis 
in real time (DART) [18] and paper spray ionization (PSI) [19, 20]. 
In PSI, the sample is deposited on paper, and the analytes are extracted by addition 





the paper. This is followed by the application of high-voltage to the paper, which generates 
charged droplets and, consequently, ionizes the analytes [19, 20]. PSI has been extensively 
used to detect drugs and metabolites from dried blood [15, 16, 21] and has demonstrated 
its capability of detecting in vivo glucuronides from urine [22]. Recently PSI has been used 
to analyze military explosives [23–25], but its use in detection of HME in biological 
samples, e.g. blood and urine, has not previously been shown. 
Cyclic peroxide explosives are readily ionized by atmospheric pressure chemical 
ionization (APCI), with TATP often observed as the ammonium adduct, and HMTD as a 
protonated ion [26, 27]. The formation of peroxide explosives complexes with alkali metal 
ions using DESI has also been described [9, 28]. Detection of TATP and HMTD in human 
skin has been demonstrated using extractive electrospray ionization (EESI) coupled with a 
desorption device [29]; yet, there remains a need for a consistent method of detection of 
peroxide explosives in biological matrices. This work demonstrates that paper spray 
ionization - high resolution mass spectrometry (PSI-HRMS) provides a simple, quick and 
efficient method for reliably detecting TATP and HMTD via adduct formation in biological 
samples, such as blood and urine. 
Trace detection of explosives relies on extracting residues from hair, clothing 
and/or other personal items [30]. Although hair studies indicate that explosives, such as 
TATP, trinitrotoluene (TNT) and ethylene glycol dinitrate (EGDN), remain on human hair 
for days after exposure [31], fixated hygiene may prevent explosive residues to endure. 
Thus, detection of a metabolite from biological matrices (e.g. blood or urine) could be 





explosives. Also, the detection of TATP-O-glucuronide in the urine of bomb-sniffing dogs 







Figure 3-1. Chemical structure of TATP, TATP metabolites (TATP-OH and TATP-O-






Materials and Methods 
Chemicals 
Optima HPLC grade methanol (MeOH), Optima HPLC grade water (H2O), Optima 
HPLC grade acetonitrile (ACN), ACS grade acetone, ACS grade methanol, ACS grade 
pentane, citric acid anhydrous, ammonium acetate (NH4OAc), dipotassium phosphate 
(K2HPO4), monopotassium phosphate (KH2PO4), magnesium chloride (MgCl2), sodium 
carbonate (Na2CO3), and potassium carbonate (K2CO3) were purchased from Fisher 
Chemical (Fair Lawn, NJ, USA). Reduced nicotinamide adenine dinucleotide phosphate 
(NADPH), 1-naphthol, hexamethylenetetramine, hydroxyacetone, formic acid (FA), 
lithium carbonate (Li2CO3) and cesium carbonate (Cs2CO3) were purchased from Acros 
Organics (Morris Plain, NJ, USA). Uridine-5’-diphosphoglucuronic acid (UDPGA) was 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Alamethicin was purchased from 
Alfa Aesar (Ward Hill, MA, USA). Silver acetate (AgOAc) was purchased from 
Mallinckrodt Specialty Chemicals (Paris, KY, USA). Deuterated acetone (D6-acetone) and 
13C-acetone were purchased from Cambridge Isotope Labs (Cambridge, MA, USA). 
Hydrogen peroxide (50 %) was purchased from Univar (Redmond, WA, USA). Dog liver 
microsomes (DLM) were purchased from Sekisui XenoTech (Kansas City, KS, USA). Dog 
whole blood with anticoagulant was purchased from Innovative Research (Novi, MI, 
USA). 
TATP was synthesized according to the literature [1]. Deuterated TATP (D18-





synthesized as above using D6-acetone, 
13C-acetone and a mixture of acetone and 
hydroxyacetone, respectively. HMTD was synthesized according to the literature [32].  
 
HPLC–HRMS Analysis 
Metabolite identification was performed by high‐performance liquid 
chromatography coupled to a Thermo Scientific Exactive high-resolution mass 
spectrometer (HPLC–HRMS) (Thermo Scientific, Waltham, MA, USA). A CTC Analytics 
PAL autosampler (CTC Analytics, Zwinger, Switzerland) was used for LC injections, 
solvent delivery was performed using a Thermo Scientific Accela 1200 quaternary pump, 
and data collection/analysis was done using Xcalibur software (Thermo Scientific, ver. 
2.1). The HPLC gradient and MS tune conditions for all TATP derivatives were previously 
described [7].  
 
In Vitro Glucuronidation from Dog Liver Microsomes 
To examine metabolism by canine uridine diphosphoglucuronosyl-transferase 
(UGT), 1mg/mL DLM, 10mM phosphate buffer (pH 7.4), 2mM MgCl2 and 50 µg/mL 
alamethicin were equilibrated on ice for 15 minutes before 1mM NADPH (CYP co-factor 
[6]) was added, and the mixture was warmed to 37 °C and shaken at 800 rpm using a 
Heating Shaking Drybath (Thermo Scientific, Waltham, MA, USA). After 3 minutes of 
subsequent equilibration, the substrate (10 µg/mL TATP or 13C3-TATP) was added; and 2 
minutes later, the reaction was initiated by addition of 5.5 mM UDPGA (UGT co-factor 





equal volume of ice cold ACN and immediately vortex-mixed to quench the reaction. The 
sample was centrifuged for 5 minutes at 14,000 rpm; and the supernatant analyzed by 
HPLC–HRMS. Negative control incubations excluded the UGT co-factor, UDPGA, to 
prevent glucuronidation. Positive control incubations used a known UGT substrate, 1-
naphthol, to promote glucuronidation [35]. 
 
In Vivo Glucuronidation from Bomb-Sniffing Dogs 
K9 units are trained on explosive odor by “operant conditioning” on a daily basis 
[36, 37]. Briefly, small containers with explosives are hidden in multiple locations, e.g. 
inside a cabinet, behind a trash can, under a drain. The handler slowly walks the dog around 
the area, allowing it to sniff and sit when it recognizes the odor it was trained to, expecting 
a positive reward.  
Multiple vials of solid TATP (0.5 g) were used for canine training. To abide with 
the police schedule, this pilot study was performed using only three bomb-sniffing 
labradors; each dog, tested twice. Urine from these canine subjects was collected in 
intervals of 1, 2, 3 hours or overnight after training exposure and, within 4 hour of 
collection, tested for the presence of TATP and its metabolites.  TATP and its metabolites 
were extracted and concentrated from the urine using a RDX solid-phase extraction (SPE) 
cartridge (Restek, Bellefonte, PA, USA) with the following procedure: the sorbent was 
conditioned with 6 mL of MeOH, equilibrated with 6 mL of H2O, followed by sample 





aliquots of MeOH/H2O (1:1, v/v), and finally, the analytes were extracted with 1 mL of 
ACN prior to HPLC–HRMS analysis. 
 
Paper Spray Ionization 
Direct analysis of peroxide explosives in biological matrices was done using paper 
spray ionization on a Thermo Scientific LTQ-Orbitrap XL HRMS (Thermo Scientific, 
Waltham, MA, USA). The paper swabs were cut as an equilateral triangle with 1 cm side 
(60° tip angle). A copper clip was used to attach an external power supply set to a specific 
voltage and to hold the paper about 3 mm from the MS inlet. The positive mode source 
parameters were as follows: paper spray voltage, 4.5 kV; capillary temperature, 275 °C; 
capillary voltage, 35 V; and tube-lens voltage, 90 V. The negative mode source parameters 
were: paper spray voltage, -4.5 kV; capillary temperature, 275 °C; capillary voltage, -15 
V; and tube-lens voltage, -84 V.  
Performance of our in-house PSI setup was determined by depositing a constant 
volume of 200 μL of a TATP standard curve made in MeOH/H2O (1:1, v/v) with d18-TATP 
as an internal standard on a paper, and ionizing it using the PSI procedure described above. 
Peroxide explosive selectivity via metal adduct formation was achieved by dissolving 
TATP in MeOH/aqueous salt solution (1:1, v/v) and HMTD in ACN/MeOH/aqueous salt 
solution (1:1:2, v/v/v), which contained approximately 50 μM of Li+, Na+, K+ and NH4
+ or 
100 μM of Cs+ and Ag+. Urine and blood samples, fortified with 1mM of TATP or HMTD, 





adduct formation. The swab type usually used was High Efficiency sampling swipes (FLIR 
Systems, Wilsonville, OR, USA, part no. FS-03-E). 
To optimize silver adduct formation using PSI, a variety of paper materials were 
tested: High Efficiency sampling swipes, Shark Skin swabs (Smiths Detection, London, 
UK, part no. 2811791-H), sample traps multi-purpose made with PTFE-coated fiberglass 
(DSA Detection, North Andover, MA, USA, part no. ST1318P), parchment specialty paper 
(Southworth, Altanta, GA, USA, part no. P874CK), phase separator 1 treated with silicone 
(Whatman, Maidstone, UK, part no. 2200 125) and Flagship copy paper (W.B. Mason, 







In Vitro Glucuronidation from Dog Liver Microsomes 
In vitro incubations established the presence of TATP-O-glucuronide in dog liver 
microsomes. When TATP was incubated with UDPGA in DLM, formation of TATP-O-
glucuronide was monitored as an intensity increase of m/z 413.1301 for the deprotonated 
ion using negative mode electrospray ionization (ESI-) or m/z 432.1712 for the ammonium 
adduct using APCI+ mode. TATP-O-glucuronide was not observed in the negative 
controls, i.e. excluding UDPGA or NADPH, indicating that TATP-OH must first be 
formed by phase I enzymes in the presence of NADPH and then further metabolized into 
TATP-O-glucuronide in the presence of UDPGA. The use of carbon-13 labeled TATP in 
the incubation mixture confirmed formation of both metabolites, TATP-OH and TATP-O-








Figure 3-2. Extracted ion chromatogram using APCI+ of a) [13C3-TATP + NH4]
+ (m/z 
243.1542), b) [13C3-TATP-OH + NH4]
+ (m/z 259.1491), and c) [13C3-TATP-O-glucuronide 
+ NH4]






In Vivo Glucuronidation from Bomb-Sniffing Dogs 
A SPE procedure for TATP and TATP-OH was developed using TATP and TATP-
OH spiked urine. Experiments indicated that MeOH/H2O was a suitable wash solution, 
with the lipophilic compounds being extracted with ACN. However, the hydrophilic 
TATP-O-glucuronide was washed away in the aqueous phase, failing to be retained by the 
sorbent material under generally accepted conditions. This observation advocates for an 
analytical technique, such as PSI, that does not require sample preparation prior to MS 
analysis. 
TATP, TATP-OH and TATP-O-glucuronide were not observed in the analysis of 
the extracted dog urine collected 1, 2 or 3 h after canine training with TATP. In contrast, 
during human studies, TATP-O-glucuronide was observed in urine as early as 2 h after 
TATP exposure [7], but since dog metabolism is different [38, 39], urine was also collected 
over a longer period of time. TATP excretion in dogs was only observed in the urine 
samples collected approximately 12 h (overnight) after training. At that time TATP-O-
glucuronide was present in the urine of all three dogs, providing good in vivo correlation 







Figure 3-3. Extracted ion chromatogram using ESI- of [TATP-O-glucuronide - H]- (m/z 
413.1301) from a) complete incubation mixture in DLM 2 h after TATP addition, b) dog 





Even though the amount of TATP was standardized, quantification of TATP-O-
glucuronide in the dog urine was deemed unnecessary because the training was 
unstandardized and each of the dogs’ handlers controlled the duration of training, testing 
location, and urine collection. Since the amount of TATP (0.5g) used in our experiment 
was significantly less than the minimum amount of explosive used for the bomb-sniffing 
dog certification testing (¼ lbs or 113.5 g) [37], it is evident that both dog and handler are 
absorbing TATP. 
 
Paper Spray Ionization 
Analysis of Pure Peroxides 
Peroxide explosives analysis was done using a homemade PSI setup in conjunction 
with HRMS (Figure 3-4). The successful operation of the PSI setup was evaluated by using 
a standard calibration curve [40]. TATP linearity was observed over the range of 10 to 
10,000 ng (Figure 3-5). Limit of detection (LOD) was determined to be 1 ng of TATP 
based on 3 × S/N ratio, and limit of quantification (LOQ) was taken to be 10 × LOD, which 














Figure 3-5. TATP calibration curve (run in triplicates) using PSI+ mode on Thermo LTQ-
Orbitrap XL. Intensity ratio of [TATP + Na]+ /[d18-TATP + Na]
+ was plotted versus amount 






Formation of multiple adducts, such as multiple alkali metals adducts, increases 
selectivity when identifying an analyte. Solutions of TATP and d18-TATP were made with 
alkali metal ions (Li+, Na+, K+) and ionized using the homemade PSI source. TATP alkali 
metal complexes were observed in all cases with confirmation from deuterated TATP. The 
collision induced dissociation (CID) fragmentation of these TATP complexes follows the 
literature [9] pattern consisting of the retention of the metal and loss of ethane (Figure 
3-6). The precursor ion, [TATP + H]+ (m/z 223.1176), was not observed; and the 
abundance of the normally observed ammonia adduct, [TATP + NH4]
+ (m/z 240.1442), 














Although previously reported at low levels by ESI [42], the TATP cesium complex 
was not observed in PSI. Reported density functional theory (DFT) calculations estimated 
that the metal ion is centered equidistant from the oxygen atoms of TATP, but slightly 
above the cavity, due to steric effects related to the size of the metal ion [9]. This suggested 
that the period 6 alkali metal was too bulky to effectively interact with TATP. 
Silver was tested as a potential adducting agent since the formation of diacyl 
peroxide silver complexes by ESI have been proposed [43]. Silver has two naturally 
occurring isotopes, with 107Ag and 109Ag having composition abundance of 52% and 48%, 
respectively [44], which increase mass assignment confidence when considering their 
specific isotopic ratio. TATP interacted with silver to create the [TATP + 107Ag]+ and 
[TATP + 109Ag]+ with m/z 329.0149 and 331.0145, respectively (Figure 3-7). Solutions of 
deuterated TATP with silver were also used to confirm the adduct ion formation as [d18-
TATP + 107Ag]+ (m/z 347.1279) and [d18-TATP + 
109Ag]+ (m/z 349.1275). Unlike the 
ammonia adduct, commonly observed by APCI+, the silver adduct is stable enough to be 
isolated and activated by high-energy collision dissociation (HCD), yielding the same 
pattern in both ESI and PSI. Similarly, as with the alkali metal complexes, the silver adduct 
was not observed in APCI, and the primary fragment consisted of the loss of ethane with 
retention of the metal (Figure 3-7). Acetone silver clusters can be easily formed [45], and 
they appear to be present in the mass spectrum of TATP (Figure 3-7). Considering acetone 
is an intrinsic part of the TATP structure, acetone silver clusters further supports the 
identification of TATP and may be used to corroborate its detection. TATP detection can 

















Figure 3-7. Averaged full scan mass spectra of 1 mM TATP with 100 μM Ag+ dopant using PSI+ mode on Thermo LTQ-Orbitrap XL. 
Sample was deposited on paper, desolvated with MeOH, ionized using 4.5 kV. TATP silver adducts, m/z 329.0149 and 331.0145 with 





Since TATP detection is often done by portable IMS, which are available in most 
ports of entry (e. g. airports), the swabs, already employed by these instruments were tested 
for PSI use [46]. TATP silver adducts formation by PSI varied with the paper used; of the 
six different types of paper tested, the TATP-silver adduct was only observed with the three 
IMS swab materials (FLIR Systems High Efficiency sampling swipes, Smiths Detection 
Shark Skin swabs and DSA Detection sample traps multi-purpose made with PTFE-coated 
fiberglass). On the other hand, m/z 245.0996 [TATP + Na]+ was formed by all tested 
materials, indicating that the larger, heavier metal ions were not easily desorbed from some 
materials, unlike sodium, which was the most stable adduct for TATP. 
  HMTD detection by PSI was challenging. HMTD has low solubility in most 
common solvents, and solutions of HMTD in pure ACN were not used because it has been 
shown that ACN suppresses HMTD and TATP ion formation [47]. In PSI, the HMTD 
principle ion (m/z 209.0768) was assigned to [HMTD + H]+, with less intense alkali metal 
complexes, [HMTD + Li]+, [HMTD + Na]+ and [HMTD + K]+, observed as m/z 215.0850, 
231.0588 and 247.0327, respectively. Isotopically labeled d12-HMTD with m/z 227.1603 
[d12-HMTD + Li]
+, m/z 243.1341 [d12-HMTD + Na]
+ and m/z 259.1080 [d12-HMTD + K]
+ 
confirmed alkali metal complex formation. Although the formation of silver complexes 
would be advantageous for the detection of HMTD because of the easily recognizable 







Analysis of Peroxides in Biological Matrices 
The peroxide explosive complexes with different alkali metals contribute to their 
confirmation in biological matrices via multiple ion identification. In addition, the high 
levels of sodium and potassium normally present in both urine and blood [48, 49] were 
leveraged for in situ analysis. When TATP (Figure 3-8) or HMTD (Figure 3-9) were 
spiked in both urine and blood without the addition of any dopant, the sodium and 










Figure 3-8. Averaged full scan mass spectra of a) urine and b) blood, fortified with 1 mM TATP using PSI+ mode on Thermo LTQ-










Figure 3-9. Averaged full scan mass spectra of a) urine and b) blood, fortified with 1 mM HMTD using PSI+ mode on Thermo LTQ-





It was thought that the capability of TATP to form silver complexes, the presence 
of acetone silver clusters in TATP samples, and the silver characteristic isotopic ratio 
would also serve as confirmatory tools in deconvolution of mass spectra from biological 
matrices. However, urine or blood solutions of TATP doped with silver did not result in 
the observation of the TATP silver adduct; the sodium and potassium adducts were the 
only TATP species present in the mass spectrum. 
Bomb-sniffing dogs were exposed to TATP, and several hours later their urine was 
collected, deposited on paper and analyzed by PSI with no further sample preparation 
(Figure 3-10). The relative abundance of [TATP-O-glucuronide – H]-, m/z 413.1301, in 
the full scan mode was low; nevertheless, it could be identified from the matrix background 
without any chromatographic separation. The detection of TATP-O-glucuronide from in 











Figure 3-10. Averaged full scan mass spectra of bomb-sniffing dog urine collected 12 h after training with TATP using PSI- mode on 






PSI promotes analysis of samples in situ by eliminating the laborious sample 
preparation step. Direct analysis is specifically important for TATP, because it is so volatile 
that sample concentration or other routine workup greatly lowers its concentration. 
However, the lack of sample preparation increases matrix background interferences. These 
were overcome by the formation of multiple alkali metal adducts with the peroxide 
explosives. The particular use of sodium and potassium adducts, which are abundant in 
blood and urine [48, 49], were exploited as an advantage, avoiding the need for an external 
ionization dopant. The formation of both sodium and potassium adducts with TATP (Fig. 
8) or HMTD (Fig. 9) increased the mass assignment confidence when identifying these 
peroxide explosives in direct analysis of blood and urine samples. Urine and blood tests 
have been widely used to trace drug abuse [50, 51], and PSI has been shown to easily and 
quickly analyze dried blood spots [15, 16, 21]. Since PSI can selectively detect peroxide 
explosives from blood and urine, it is a technique that can also be expanded to trace people 
involved in the production of illegal explosives. 
The advantages of using silver adducts for PSI analysis included the formation of 
two adducts from the isotopes of silver, the identification of the silver isotopic pattern, the 
specific fragmentation of TATP metal adducts, and the formation of acetone silver clusters; 
each helped confirm the identity of the compound. However, silver adducts were not 
formed with all peroxide explosives, not being observed with HMTD.  
Detection of peroxide explosives from biological samples can also be greatly 





unknown, we have recently described some of the metabolic pathways of TATP identifying 
that hydroxylation to TATP-OH (Fig. 1) was catalyzed by phase I enzymes, i.e. CYP2B11 
in dogs [52] and CYP2B6 in humans [7]. To extend previous findings, we assessed the 
effects of TATP metabolism in vitro and determine that TATP-OH undergoes phase II 
glucuronidation to TATP-O-glucuronide (Fig. 1) in canine liver microsomes. Since 
glucuronide conjugates are often excreted in urine [6], the potential excretion of TATP 
after glucuronidation in canines was also investigated. The urine of bomb-sniffing dogs, 
collected approximately 12 h after training with TATP, underwent the established SPE 
clean-up procedure, HPLC separation method and HRMS analysis.  The results were 
compared to the in vitro data and TATP-O-glucuronide was confirmed in the dogs’ urine. 
In order to quickly detect TATP absorption in the field, PSI is proposed. The same 
bomb-sniffing dogs’ urine samples were also analyzed using PSI- with no sample 
preparation or chromatographic separation, and TATP-O-glucuronide was observed in the 
full scan (Fig. 10). The detection of TATP-O-glucuronide from the urine of bomb-sniffing 
dogs exposed to TATP provides strong support for the use of PSI in forensic analysis of in 
vivo metabolites [15, 22]. 
Detection of peroxide explosives by PSI has several advantages.  It increases 
throughput by simplifying or completely eliminating sample preparation steps. It 
minimizes false positive detection via increased selectivity gained by complex formations 
with multiple alkali metals. Coupled with mass spectrometry, PSI allows trace detection, 





technologies, in combination with PSI for field deployment, could greatly improve on-site 
analysis and forensic efficiency [14]. 
 
Conclusions 
This work explored the use of PSI-HRMS as a valuable detection method for 
TATP, HMTD and their metabolites in blood and urine. Without the need for 
chromatography or extensive sample clean-up, the presence of TATP or HMTD in 
biological matrices can be confirmed with PSI-HRMS using one or more of the following: 
1) the fragmentation patterns of the peroxide; 2) its adducts with various alkali metals; 3) 
the isotope patterns resulting for its silver adducts.  Although TATP and HMTD form alkali 
metal adducts, we have found that sodium and potassium, both abundant in blood and urine, 
can serve as in situ dopants to assist in the ionization of peroxide explosives. In this case, 
the matrix background, which accompanies biological samples, can be used 
advantageously in promoting adduct formation. We have demonstrated the use of PSI-
HRMS to analyze TATP and HMTD in fortified blood and urine samples, and its practical 
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Triacetone triperoxide (TATP) and hexamethylene triperoxide diamine (HMTD) 
are prominent explosive threats. Mitigation of peroxide explosives is a priority among the 
law enforcement community. Canine (K9) units are trained to recognize the scent of 
peroxide explosives. Herein, the metabolism, blood distribution and toxicity of peroxide 
explosives is investigated. HMTD metabolism studies in liver microsomes identified two 
potential metabolites, tetramethylene diperoxide diamine alcohol aldehyde (TMDDAA) 
and tetramethylene peroxide diamine dialcohol dialdehyde (TMPDDD). However, blood 
stability studies in dogs and humans showed that HMTD was rapidly degraded, whereas 
TATP remained for at least one week. Toxicity studies in dog and human hepatocytes 
indicated minimum cell death for both TATP and HMTD. 
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Energetic materials can be classified by chemical structure; including nitrate esters, 
nitroaromatics, nitroamines, peroxide and others. The toxicity of most military explosives 
is well-characterized, with even some therapeutic properties being identified. For example, 
nitrate ester explosives, such as nitroglycerin and PETN (pentaerythritol tetranitrate), are 
widely used as vasodilators to treat angina (FDA 2014). Ill side effects have been linked to 
other explosives. Nitroaromatic explosives, such as TNT (2,4,6-trinitrotoluene), picric acid 
(2,4,6-trinitrophenol) and tetryl (2,4,6-trinitrophenyl-N-methylnitramine), may cause 
cytotoxicity, their metabolic pathways include single- or two-electron enzymatic reduction 
that forms radical species (Nemeikaite-Ceniene et al. 2006). Nitroamine explosives, such 
as RDX (1,3,5-trinitro-1,3,5-triazinane) and HMX (1,3,5,7-tetranitro-1,3,5,7-tetrazoctane), 
may be carcinogenic, their metabolic pathways promote the formation of N-nitroso species 
which cause genetic damage (Pan et al. 2007). However, the metabolic pathways and 
toxicity of peroxide explosives, such as TATP (triacetone triperoxide) and HMTD 
(hexamethylene triperoxide diamine, Figure 4-1) has not been thoroughly investigated 
(Colizza et al. 2019, Gonsalves et al. 2020). 
TATP was used in the 2015 Paris attack, the 2016 airport bombings in Brussels, the 
2017 concert bombing in Manchester, UK, the 2018 bombings in Surabaya, Indonesia, and 
the 2019 assaults in hotels and churches across Colombo, Sri Lanka (Rossi et al. 2019). 
Peroxide explosives are a threat because they are easily initiated and readily synthesized 
from household items. (Oxley, Smith, and Chen 2002, Oxley, Smith, Chen, et al. 2002, 





to personnel, such as canine (K9) detection units and scientists developing detection 
devices (Oxley et al. 2015). Understanding the absorption, distribution, metabolism, 
excretion and toxicity (ADMET) of peroxide explosives is essential to safe handling of 
these chemicals. Collaborating with K9 units, we established the hepatic metabolism of 
TATP, in which TATP undergoes hydroxylation into TATP-OH, followed by 
glucuronidation into TATP-O-glucuronide, which is excreted in the urine of both human 
and canines exposed to TATP vapours (Gonsalves et al. 2020).  
TATP is a highly volatile compound with vapour pressure estimated around 5.91 x 
10-5 atm at 25 °C (Oxley et al. 2005, Damour et al. 2010), and HMTD is lipophilic, with 
partition coefficient (cLogP) of 1.11 (PerkinElmer 2017) indicating inhalation and dermal 
exposure are the most probable routes of absorption. Both TATP and HMTD contain three 
peroxide functionality, suggesting potential similarities with the side effects of hydrogen 
peroxide (H2O2) exposure. Risks of hydrogen peroxide absorption by inhalation include 
coughing and temporary dyspnoea, and by dermal contact include from whitening of the 
skin to blistering and severe skin damage (Watt et al. 2004). 
It has been reported that authorities found TATP in the blood of the Brussels 2016 
suicide bombers (Goulard 2016). Considering the presence of catalase in blood, which 
facilitates the cleavage of peroxide bonds in H2O2 (Watt et al. 2004), and the instability of 
the TATP cyclic multi-peroxidic structure, this claim seemed unlikely. However, if TATP 
were stable in blood, the potential forensic evidence is obvious.  
Once absorbed, compounds are either excreted unchanged or are distributed to the 





P450 (CYP), and/or phase II conjugation reactions, catalysed by glutathione S-transferase 
(GST), uridine diphosphoglucuronosyltransferase (UGT) or others, occur, producing 
metabolites that can be effectively excreted from the body (Parkinson et al. 2018). Some 
metabolites of TNT, including 4-amino-2,6-dinitrotoluene and 2-amino-4,6-dinitrotoluene, 
have been found in the urine and bound to haemoglobin in the blood of munition workers. 
The chronic exposure of these workers to TNT caused anaemia, hepatitis and cataracts, 
exemplifying the importance of biomarkers to track contact and prevent chronic exposure 
to explosives (Sabbioni et al. 2005, Voříšek et al. 2005). Even though working with 
peroxide explosives falls under the protection of several standard operating procedures, 
information about their blood distribution, metabolism and toxicity is imperative to ensure 
the safety of K9 units, where both the dog and human handler are constantly exposed to 












Materials and Methods 
Chemicals 
Optima HPLC grade methanol (MeOH), Optima HPLC grade water (H2O), Optima 
HPLC grade acetonitrile (ACN), ACS grade acetone, ACS grade methanol, ACS grade 
pentane, citric acid, ammonium acetate (NH4OAc), dipotassium phosphate (K2HPO4), 
monopotassium phosphate (KH2PO4), magnesium chloride (MgCl2), Tris-base, 
hydrochloric acid (HCl) and reduced glutathione (GSH) were purchased from Fisher 
Chemical (Fair Lawn, NJ, USA). Reduced nicotinamide adenine dinucleotide phosphate 
(NADPH), hexamethylenetetramine, 1-naphthol and hydroxyacetone were purchased from 
Acros Organics (Morris Plain, NJ, USA). Uridine-5’-diphosphoglucuronic acid (UDPGA), 
bovine serum albumin (BSA), glycerol and dimethyl sulfoxide (DMSO) were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Bupropion, and alamethicin were purchased 
from Alfa Aesar (Ward Hill, MA, USA). Ticlopidine was purchased from Tokyo Chemical 
Industry (Tokyo, Japan). Staurosporine was purchased from Cayman Chemical (Ann 
Arbor, MI, USA). Deuterated acetone (D6-acetone), deuterated formaldehyde (D2-
formaldehyde), 13C-acetone and 15N-ammonium hydroxide were purchased from 
Cambridge Isotope Labs (Cambridge, MA, USA). Hydrogen peroxide (50 %) was 
purchased from Univar (Redmond, WA, USA). Collagen coated 96 well-plates were 
purchased from Gibco (Gaithersburg, MD, USA). Human liver microsomes (HLM), dog 
liver microsomes (DLM), cryopreserved human hepatocytes (CryostaX, 5 donor pool), 
cryopreserved dog hepatocytes, OptiThaw media, OptiPlate media and OptiCulture media 





anticoagulant was purchased from Innovative Research (Novi, MI, USA). Human whole 
blood with anticoagulant was purchased from ZenBio (Research Triangle Park, NC, USA); 
blood was tested in accordance with FDA regulations prior to shipping.  
 
Synthesis of peroxide explosives 
TATP was synthesized according to the literature (Oxley et al. 2013). Deuterated 
TATP (d18-TATP), carbon-13 labelled TATP (
13C3-TATP) and hydroxy-TATP (TATP-
OH) were synthesized as above using d6-acetone, 
13C-acetone and a mixture of acetone and 
hydroxyacetone, respectively. HMTD was synthesized according to the literature 
(Wierzbicki and Cioffi 1999). A similar reported procedure was used to synthesize 
deuterated HMTD (d12-HMTD) and nitrogen-15 labelled HMTD (
15N2-HMTD) using d2-
formaldehyde and 15N-ammonium hydroxide, respectively (Nielsen et al. 1979). 
 
Instrumental analysis 
Metabolite identification was performed by high‐performance liquid 
chromatography coupled to a Thermo Scientific Exactive high-resolution mass 
spectrometer (HPLC–HRMS) (Thermo Scientific, Waltham, MA, USA). A CTC Analytics 
PAL autosampler (CTC Analytics, Zwinger, Switzerland) was used for LC injections, 
solvent delivery was performed using a Thermo Scientific Accela 1200 quaternary pump, 






Quantification of blood incubations was performed by high‐performance liquid 
chromatography coupled to an AB Sciex Q-Trap 5500 triple quadrupole mass spectrometer 
(HPLC–MS/MS) (AB Sciex, Toronto, Canada). A CTC Analytics PAL autosampler was 
used for LC injections, solvent delivery was performed using a Thermo Scientific Accela 
1200 quaternary pump and data collection/analysis was done with Analyst software (AB 
Sciex, ver. 1.6.2).  
The HPLC method for metabolite identification of all HMTD derivatives was as 
follow: sample of 40 µL was injected into LC flow at 250 µL/min of 5 % MeOH (A) and 
95 % aqueous 10 mM NH4OAc (B) in positive ionization mode or aqueous 200 μM 
NH4OAc, 200 μM NH4Cl and 0.1 % FA (C) in negative ionization mode for introduction 
onto an Analytical Advantage FluroPhase PFP column (100 × 2.1 mm i.d., particle size 5 
µm, Analytical Sales and Services, Flanders, NJ, USA). Initial conditions were held for 2 
min before ramping to 2%A/98%B or C over 1 min. This ratio was held for 2 min before 
reverting to initial conditions over 30 s for additional 2 min re-equilibration. The HPLC 
method for quantification of HMTD and d12-HMTD was the same as above, except the 
sample volume was reduced to 20 µL and the gradient was quickly ramped over the course 
of only 3 s instead 1 min.  
The HPLC gradient and MS tune conditions for all TATP derivatives were 
previously described (Gonsalves et al. 2020). The MS tune conditions for all HMTD 
metabolite identification and quantification analysis are shown in Table 4-1. The Q-trap 
5500 MS multiple reaction monitoring (MRM) conditions are shown in Table 4-2. TATP 





d12-HMTD as internal standards, respectively. The relative standard deviation (RSD) for 










Table 4-1. Mass spectrometer tune conditions. 
Parameters Exactive Q-trap 5500 
 ESI+ APCI+ ESI- APCI- APCI+ 
Spray voltage (kV) 4 N/A -3.4 N/A N/A 
Discharge or nebulizer current (μA) N/A 6 N/A 10 3 
Vaporizer temperature (°C) N/A 250 N/A 200 250 
Sheath gas or ion source gas 1 (AU) 30 25 30 35 15 
Auxiliary gas or ion source gas 2 (AU) 15 15 15 17 3 
Capillary voltage or declustering potential (V) 28 35 -53 -25 26 
Capillary temperature (°C) 245 275 275 150 N/A 
Tube lens voltage or entrance potential (V) 90 35 -110 -100 10 
Skimmer voltage (V) 18 14 -36 -18 N/A 
Curtain gas (psi) N/A N/A N/A N/A 15 
Collision gas (psi) N/A N/A N/A N/A 5 









Table 4-2. Triple quadrupole mass spectrometer (Q-trap 5500) MRM conditions. 
Parameters TATP HMTD 
Deuterated IS MRM transitions (m/z) 258 → 80, 46 221 → 154, 94 
Collision energy (V)  11, 27  5, 13 
Collision cell exit potential (V)  14, 20  54, 10 
Analyte MRM transition (m/z) 240 → 74, 43 209 → 145, 88 
Collision energy (V)  11, 28  7, 13 







Metabolism of HMTD 
The metabolism of HMTD was investigated via metabolite identification and 
substrate depletion in liver microsomes. The 1 mL incubation mixture contained 10 mM 
phosphate buffer (pH 7.4), 2 mM MgCl2, 1 mM NADPH (CYP cofactor (Parkinson et al. 
2018)) and 1mg/mL HLM or 0.5 mg/mL DLM. After 3 min of equilibration in a Heating 
Shaking Drybath (Thermo Scientific, Waltham, MA, USA) set to body temperature, 37 °C, 
and 800 rpm, the reaction was started with the addition of 1 mg/mL of each HMTD (or 1 
µM for substrate depletion experiment), d12-HMTD or 
15N2-HMTD, maintaining the 
organic concentration at less than 1 % (Chauret et al. 1998). Negative controls consisted 
of the incubation mixture excluding either microsomes or NADPH. Positive control used 
100 µM bupropion as the substrate (Faucette et al. 2000). At different time points, an 
aliquot was transferred to a vial containing equal volume of ice cold ACN and immediately 
vortex-mixed to quench the reaction. The sample was centrifuged for 5 min at 14,000 rpm, 
and the supernatant analysed by HPLC–HRMS. The substrate depletion experiment was 
quantified by HPLC–MS/MS. 
Phase II metabolism by glutathione S-transferase (GST) was probed by 
equilibrating 5 mM GSH (GST cofactor (Parkinson et al. 2018)) for 5 min in the incubation 
mixture including HLM (1 mg/mL) or human liver cytosol (2 mg/mL) before the substrate 
was added. Positive control used 10 µM ticlopidine, an GST substrate (Ruan and Zhu 
2010). To examine phase II metabolism by uridine diphosphoglucuronosyltransferase 
(UGT), HLM (1 mg/mL), buffer, MgCl2 and alamethicin (50 µg/mL in MeOH/H2O) were 





37 °C and shaken at 800 rpm. After 3 min of subsequent equilibration, the substrate was 
added; and 2 min later, the reaction was started by the addition of 5.5 mM UDPGA (UGT 
co-factor (Parkinson et al. 2018)). Positive control used 100 µM 1-naphthol, an UGT 
substrate (Di Marco et al. 2005). Phase II metabolite samples were analysed as above using 
HPLC–HRMS. 
 
Blood stability of peroxide explosives 
The stability of peroxide explosives in blood was examined. Human and canine 
whole blood samples from multiple donors, or water, were transferred to vacutainers 
containing heparin, and fortified with TATP or HMTD (less than 1 % organic). The 1 mL 
mixture was incubated in closed vials at 37 °C and 800 rpm in a heated shaker for up to 1 
week for TATP and for up to 1 h for HMTD. To stop the reaction, 1.5 mL of cold MeOH 
and 2.5 mL of cold ACN, containing the internal standard solution (d18-TATP or d12-
HMTD), were added to the vial and immediately vortexed. The samples were centrifuged 
twice, first at 4,400 rpm for 10 min, then at 14,000 rpm for 5 min, prior to quantification 
by HPLC–MS/MS.  
 
Toxicity of peroxide explosives 
Cryopreserved human and dog hepatocytes were prepared according to 
manufacturer protocols. Briefly, a cryotube was thawed in a 37 C water bath for 
approximately 60 seconds, re-suspended in pre-warmed (37 ± 1 °C) OptiThaw media, and 





aspirated and discarded, and the cell pellet was re-suspended with OptiPlate media (15 
mL). The hepatocytes were seeded into a collagen coated 96-well plate at the recommended 
seeding density (0.75 × 106 cells/ mL, 75 μL/ well). The plate was placed in a 37 °C 
humidified CO2 static incubator for 3 h to allow the cells to attach and adhere to the plate. 
The plate was then removed from the incubator; media containing non-attached cells was 
removed; and the cells were overlaid with 75 μL of 2-8°C of OptiCulture media, and 
incubated for 24 h. The cells were then dosed with incubation media (75 µL/well) 
containing various concentrations of TATP, positive control staurosporine (2 µM) (Feng 
and Kaplowitz 2002) or vehicle control 0.1% DMSO with media change after 12 h for a 
total treatment of 24 h (Amaeze et al. 2019). 
Cell death was assessed using the LDH-GloTM Cytotoxicity Assay (Promega, 
Madison, WI, USA) according to manufacturer protocol. The LDH reagent was prepared 
by mixing LDH Detection Enzyme Mix and Reductase Substrate 1:0.005 (v/v). Following 
the 24 h incubation period, the plate was removed from the incubator and 2 μL of the media 
of each well was transferred to another 96 well-plate well containing 48 μL of LDH storage 
buffer (200mM Tris-HCl, 10% glycerol and 1% BSA). The LDH reagent (50 μL) was 
added to the diluted media in each well and allowed to sit at room temperature for 1 h prior 
to luminescence measurement. 
Cell viability was assessed using the CellTiter-Glo® 2.0 Assay (Promega, Madison, 
WI, USA) according to manufacturer protocol. Following the 24 h incubation period and 
preparation for the cell death assay, the Cell Titer Glo 2.0 reagent (75 μL) was added to the 





lysis, and after 10 min luminescence was measured using a GloMax Discover (Promega, 






Metabolism of HMTD 
Data mining uncovered the possibility of two metabolites with the presence of m/z 
231.0588 (HMTD M1) and 247.0327 (HMTD M2), supported by formation of their 
labelled counterparts in incubations with labelled HMTD - m/z 242.1278 (d12 HMTD M1) 
and 258.1017 (d12 HMTD M2), or m/z 233.0528 (
15N2-HMTD M1) and 249.0268 (
15N2-
HMTD M2) (Table 4-3, Figure 4-2). These masses were not observed in incubation 
mixtures without microsomal enzymes (Figure 4-2) but were observed in incubation 
mixtures with enzymes but without NADPH, albeit, at significantly lower levels (Figure 
4-2). This observation indicates the reaction is catalysed primarily by NADPH-dependent 






Figure 4-2. Extracted ion chromatogram using ESI+ of m/z 231.0588 (HMTD M1) from 
HMTD a) in complete incubation mixture, b) incubation mixture without NADPH, c) 























HMTD C6H12N2O6 [HMTD + H]
+ 209.0768 209.0771 0.307 5.09 
d12-HMTD C6D12N2O6 [d12-HMTD + H]




+ 211.0709 211.0714 0.468 5.09 
TMDDD C6H10N2O6 [TMDDD + H]













HMTD M1 C6H12N2O6Na [C6H12N2O6 + Na]
+ 231.0588 231.0590 0.273 1.61 
HMTD M2 C6H12N2O6K [C6H12N2O6 + K]




+ 242.1278 242.1280 0.198 1.67 
d12-HMTD M2 C6HD11N2O6K [C6HD11N2O6 + K]
















Detection of m/z 231.0588 and 247.0327 at the very onset of the incubation 
procedure, 30 seconds from the start, prevented traceability of their formations over time. 
Enzymatic homolytic cleavage of the peroxide bond could be rapidly catalysed by 
microsomal enzymes (Yeh et al. 2007). For HMTD and 15N2-HMTD, this argument would 
fit observations; however, for d12-HMTD such a reaction would result in the formation of 
m/z 243.1341 [C6D12N2O6 + Na]
+ as shown in the bottom structure in Figure 4-3. This 
metabolite was not observed; instead, the ion m/z 242.1278 was observed, suggesting a 













The mass-to-charge ratio of the sodium or potassium adduct of HMTD and its 
suspect metabolites are shown in Table 4-3. These m/z values appear to be the sodium and 
potassium salts of HMTD, but these adducts were not observed via HPLC-HRMS 
described conditions, even when these cations were present in excess. As Figure 4-3 
suggests homolytic cleavage and concomitant proton exchange would form new species 
with the same elemental composition as HMTD with the addition of sodium 
(C6H12N2O6Na
+) or potassium (C6H12N2O6K
+). However, the small offset in retention 
times may indicate two different metabolites are formed with each having their sodium and 







Figure 4-4. Extracted ion chromatogram using ESI+ of a) m/z 231.0588 (HMTD M1), and 






HMTD, similar to TATP, is best ionized by APCI (Colizza et al. 2014). On the 
other hand, tetramethylene diperoxide diamine dialdehyde (1,2,6,7,4,9-tetraoxadiazecane-
4,9-dicarbaldehyde, TMDDD, Figure 4-1), a known decomposition product of HMTD 
favours ESI ionization (Colizza et al. 2018). We have previously observed that under 
described HPLC conditions TMDDD elutes earlier than HMTD, suggesting that the open-
ring structures would have less retention than the cyclic HMTD. The elemental 
composition of HMTD metabolites and their similar retention times to TMDDD has led us 
to speculate on their structures (Figure 4-1).  
Investigations into the decomposition products of HMTD using density functional 
theory (DFT) calculations proposed tetramethylene diperoxide diamine alcohol aldehyde 
(9-(hydroxymethyl)-1,2,6,7,4,9-tetraoxadiazecane-4-carbaldehyde, TMDDAA, Figure 
4-1) as the first intermediate, formed with energy barrier of 30.2 kcal/mol, and 
tetramethylene peroxide diamine dialcohol dialdehyde (N,N'-
(peroxybis(methylene))bis(N-(hydroxymethyl)formamide), TMPDDD, Figure 4-1) as the 
second intermediate, formed with energy barrier of 26.8 kcal/mol (Oxley et al. 2016). 
However, experimental data only detected the known di-aldehyde product, TMDDD 
(Oxley et al. 2016). This suggests that catalytic activity is required to overcome the 
activation barrier and start the degradation process of HMTD. Thus, the sodium or 
potassium adducts of either TMDDAA and TMPDDD are reasonable enzymatic products 
of HMTD.  
HMTD was investigated for phase II metabolism routes of glutathione and 





incubated with the glutathione-S-transferase (GST) co-factor, GSH, or the uridine 
diphosphoglucuronosyltransferase (UGT) co-factor, UDPGA. If the peroxide bonds of 
HMTD were cleaved, it would not be surprising that HMTD would degrade to its synthetic 
precursors - ammonia, formaldehyde and hydrogen peroxide, which were below the limit 
of our mass detector.  
HMTD was incubated in human and canine liver microsomes since both members 
of the K9 detection team are exposed. Depletion of HMTD as first-order kinetics HMTD 
(Słoczyńska et al. 2019) shown by linearity of natural log of percent remaining substrate 







 t1/2 is the half-life and kdep is the slope of the substrate depletion plot. 
 
The half-life of HMTD in liver microsomes was estimated to be 62 and 58 min in humans 







Figure 4-5. HMTD percent remaining (ln-transformed) in human (HLM, ●) and dog liver 
microsomes (DLM, ♦). Substrate depletion experiments were done in triplicates by 
incubating HMTD (1 µM) in 1 mg/mL HLM or 0.5 mg/mL DLM with 10 mM phosphate 






Blood stability of peroxide explosives 
Blood is responsible for compound distribution in the body, e.g. transport to the 
liver for hepatic metabolism. Blood stability experiments were accomplished by incubating 
HMTD in human and canine whole blood at body temperature, and sampling it in intervals 
of 10 min for 1 h for analysis. Because it is known that HMTD undergoes decomposition 
in humid environments (Oxley et al. 2016), the results in blood were compared to 
experiments done in pure water. Most of the analyte was gone after 10 min, and the rate of 
its depletion in pure aqueous media was insignificant compared to that of the blood, 
strongly suggesting enzymatic degradation in the latter media (Figure 4-6).  
In vitro and in vivo metabolism data suggest TATP is stable in the body. To further 
support this observation, the stability of TATP in blood compared to that of pure water was 
examined with measurements taken every day for 1 week. Approximately 40 and 54 % 
TATP was still present in human and canine whole blood, respectively, after 1 week 
incubation at 37 °C (Figure 4-6), indicating that TATP was not degraded by blood 
enzymes. TATP volatility in warm aqueous solution was evident (Figure 4-6) as only 
about 23% TATP remained in closed vials after 7 days (Colizza et al. 2019). However, 
TATP depletion from both human and canine blood was not as extensive as from water 
(about 50 % difference), suggesting some stable binding to blood proteins, to prevent 











Figure 4-6. Percent remaining of a) TATP and b) HMTD in human blood (■), dog blood (■) and water (■). Blood stability experiments 
were done in triplicates by incubating TATP or HMTD (10 μg/mL) in human whole blood, canine whole blood and water (1 mL) at 37 





Toxicity of peroxide explosives 
The toxicity of TATP and HMTD was assessed by treating dog and human 
hepatocytes with TATP or HMTD and comparing their cellular viability and cellular death 
as two complementary assays (Figure 4-7). Cell viability was determined by measuring 
adenosine triphosphate (ATP), the principal molecule for storing and transferring energy, 
therefore indicating the presence of metabolically active cells (Maehara et al. 1987). Cell 
death was determined by measuring lactate dehydrogenase (LDH), a cytosolic enzyme that 
is released upon disruption of the plasma membrane, therefore, widely used as a 
cytotoxicity marker (Kumar et al. 2018). TATP appears to maintain a consistent ATP 
production and LDH release regardless of the TATP concentration in humans and dogs. 
Similarly, HMTD does not appear to indicate a dose response, with constant cell viability 












Figure 4-7. Percent luminescence of ATP production (■) and LDH release (■) relative to untreated control in a) human hepatocytes 
treated with TATP, b) dog hepatocytes treated with TATP, c) human hepatocytes treated with HMTD and d) dog hepatocytes treated 
with HMTD. Toxicity experiments were done in eight trials by incubating (0.1 to 200 μM) TATP or HMTD in human and dog 






Peroxide explosives, such as TATP and HMTD, are the compounds of choice by 
terrorists because it is easily synthesized from household items (Rossi et al. 2019). Law 
enforcement K9 units, handlers and dogs, are regularly exposed to various explosives as 
part of the routine, since canines are currently one of the most reliable detection techniques 
used to find an explosive (Harper and Furton 2007). Training includes peroxide explosives 
even though little is known about their toxicity. Our previous studies of TATP indicate 
similar ADMET in canine and human; we established its absorption by inhalation, its 
hepatic metabolism, comprising of hydroxylation followed by glucuronidation, and its 
excretion in urine as TATP-O-glucuronide (Colizza et al. 2019, Gonsalves et al. 2020). 
Herein, the microsomal metabolism of HMTD was investigated, in addition to the blood 
stability and hepatocyte toxicity of both TATP and HMTD in dogs and humans.  
HMTD is inherently unstable, its cyclic structure has three peroxide bonds and a 
very strained ring configuration due to a planar 3-fold coordination on the two bridgehead 
nitrogen atoms (Schaefer et al. 1985). The metabolism of this peculiar compound was 
investigated in human liver microsomes. Metabolite identification, using HPLC-HRMS, as 
m/z 231.0588 (C6H12N2O6Na
+) and 247.0327 (C6H12N2O6K
+) was supported by the 
formation of their labelled counterparts in incubations with labelled HMTD (d12-HMTD 
and 15N2-HMTD).  
The optimized analytical method used to detect the metabolite indicated a similar 
retention time and ionization technique (ESI) to TMDDD, rather than HMTD, suggesting 





sodium and potassium species suggests the formation of different metabolites. Possibly 
one and two peroxide cleavages occur, forming two metabolites with the same elemental 
composition with each having either a sodium or potassium adduct. Previous studies into 
the decomposition of HMTD proposed TMDDAA and TMPDDD as its degradation 
products (Oxley et al. 2016), instead, these could be its enzymatic products, as their mass-
to-charge matched the observed metabolites. 
No metabolites from incubations with GSH or UDPGA for phase II metabolism 
were observed. Nonetheless, if the peroxide bonds of HMTD were cleaved, and smaller 
hydrophilic compounds such as ammonia, formaldehyde and hydrogen peroxide, the 
precursors of HMTD, were formed, conjugation reactions would not be necessary to 
promote excretion. 
Blood stability studies in dogs and humans showed that HMTD was rapidly 
degraded, whereas 54 and 40 % TATP remained after 1 week in dog and human, 
respectively. Catalase, an enzyme found in red blood and liver cells, is known to 
decompose hydrogen peroxide into water and oxygen (Miller 1958, Watt et al. 2004). Here, 
it might be responsible for the cleavage of HMTD peroxide bonds and promoting its rapid 
degradation. Unlike HMTD, TATP possesses methyl groups that may create enough steric 
hindrance to prevent catalase from reaching its peroxide bonds preserving its cyclic 
structure. Our previous studies on TATP established its hepatic metabolic pathway 
consisting of hydroxylation of its accessible methyl group (Colizza et al. 2019, Gonsalves 






A recent mass spectrometric study, in which explosives were screened for recovery 
efficiency from various matrices, claimed that HMTD was not observed in dried blood 
samples because it did not form gas phase ions easily (Irlam et al. 2019); our observation 
of HMTD degradation in blood may better explain that observation. We also observed 
decrease in ionization efficiency of HMTD and d12-HMTD (IS) in blood samples, which 
is indicative of matrix interferences; however, the use of deuterated internal standard 
considerably improved the quantification of HMTD in whole blood and may assist in other 
challenging matrices.  
As previously mentioned, the Brussels authorities found TATP in the blood of 
suicide bombers (Goulard 2016). Our data, which shows the stability of TATP in blood 
over time, clearly supports their findings. In addition, the presence of TATP in dried blood 
spots aged 1 week has been reported (Ezoe et al. 2015), but the stability of TATP in liquid 
blood at body temperature over time had not, until now, been established. The stability of 
TATP in whole blood advocates for the use of blood tests as a forensic tool to screen those 
suspected to be involved in explosive terrorist attacks. 
Toxicity studies, which involved treating dog and human hepatocytes with TATP 
and HMTD, indicated minimum cell death, suggesting these peroxide explosives are not 
toxic. Comparably, H2O2, one of their reactants, is a harmless at 3 %, being used even by 
veterinarians to induce emesis in dogs; but at higher concentrations, it can cause irritation 
to the dog’s stomach, leading to more severe medical conditions (Khan et al. 2012). 
However, the larger TATP depletion from sublimation in water than in both human and 





haemoglobin. This observation suggests possible toxicity in cell lines other than 
hepatocytes and implies a health concern, since some protein binding are linked to toxicity, 
as in the case of TNT, where nitroso metabolites covalently react with cysteine residues of 
haemoglobin (Leung et al. 1995, Sabbioni et al. 2005). 
This paper is the first to examine some aspects of HMTD metabolism and toxicity 
of peroxide explosives. It also elucidates the stability of peroxide explosives in blood, and 
proposes blood tests as evidence of TATP exposure. Further investigation into the ADMET 
of peroxide explosives is necessary in order to understand the long term side effects of 







HMTD metabolism was initially probed in liver microsomes, and with the 
assistance of HMTD derivatives, deuterated-HMTD and 15N2-HMTD, potential 
metabolites were identified as TMDDAA and TMPDDD. However, subsequent blood 
studies in dogs and humans showed that HMTD was rapidly degraded in blood, possibly 
by the blood enzyme catalase, which is known to cleave peroxide bonds. Thus, hepatic 
metabolism of HMTD may not be of importance. In contrast, TATP remained in blood for 
at least one week. Blood tests have been widely used to trace drug abuse, and as suggested 
herein, it can be used as viable evidence of exposure to this illicit explosive. TATP and 
HMTD did not indicate toxicity in dog and human hepatocytes. However, the possible 
binding of TATP to blood proteins suggests possible toxicity in other cell lines.  
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5. APPENDIX A 
 
Characterization of Encapsulated Energetic Materials for Trace 



































Figure A-3. Overlaid IR spectra of the vapor released from pure ETN compared with the vapor released from ETN encapsulated with 




































Figure A-7. Overlaid GC chromatogram, with magnification around the baseline, of the 
vapor released from pure TATP compared with the vapor released from TATP 






Figure A-8. Overlaid GC chromatogram, with magnification around the baseline, of the 
vapor released from pure TNT compared with the vapor released from TNT encapsulated 






Figure A-9. GC chromatogram of the vapor release from PS-blank and PEI-blank at 150 








Figure A-10. Full scan mass spectrum of TATP (from chromatogram at RT 3.0min), ETN 
(from chromatogram at RT 7.9min) and TNT (from chromatogram at RT 11.6 min) using 


















































6. APPENDIX B 
 






























Figure B-2. Extracted ion chromatogram of ticlopidine glutathione metabolite from 
ticlopidine metabolized by gluthathione S-trasferase (GST) after 1h incubation, presented 






Figure B-3. Extracted ion chromatogram of naphthol glucuronide metabolite from 1-
naphthol metabolized by uridine diphosphoglucuronosyltransferase (UGT) after 15 min 






Figure B-4. Extracted ion chromatograms of triacetone triperoxide (TATP), hydroxy-
triacetone triperoxide (TATP-OH) and dihydroxy-triacetone triperoxide (TATP-(OH)2) 









Figure B-5. Extracted ion chromatogram of TATP-OH from TATP incubations in human 
liver microsomes (HLM), dog liver microsomes (DLM) and rat liver microsomes (RLM). 











Figure B-6. Extracted ion chromatograms using atmospheric pressure chemical ionization 
(APCI+) of possible TATP reduced glutathione (GSH) metabolites after 2h incubation. 
[M+H]+ and [M+NH4]
+ are illustrated, though other adducts were searched for. Other 
ionization methods, such as electrospray ionization (ESI) in positive and negative mode 
and APCI in negative mode, were also tested (not shown). No TATP-GSH metabolites 












Figure B-7. Extracted ion chromatogram of [TATP-O-glucuronide + NH4]
+ (m/z 
432.1712) using APCI+, showing formation of TATP-O-glucuronide at 4.26 min as 
incubation of TATP progressed. Glucuronidation samples were concentrated prior to high-











Figure B-8. Extracted ion chromatogram of benzydamine N-oxide metabolite from 
benzydamine metabolized by recombinant flavin monooxygenase 3 (rFMO3) after 10 min 






Figure B-9. TATP-OH depletion from incubations in CYP2B6 with (w/) or without (w/o) 






Figure B-10. Lineweaver-Burke plot, used to fit the equation: 1/v = (KM/Vmax × 1/[S]) + 






Figure B-11. Eadie-Hofstee plot, used to fit the equation: v = (-KM × v /[S]) + Vmax to yield 






Figure B-12. Hanes-Woolf plot, used to fit the equation: [S]/v = [S]/Vmax + KM/Vmax to yield 






Table B-1. Hydroxy-triacetone triperoxide (TATP-OH) formation from triacetone 
triperoxide (TATP) incubations with recombinant cytochrome P450 (rCYP) and 
recombinant flavin monooxygenase (rFMO) 
Incubation matrix [TATP-OH] (µM) 
HLM 1.47 ± 0.07 
rCYP control not observed 
rCYP1A2 not observed 
rCYP2B6 5.59 ± 0.3 
rCYP2C9 not observed 
rCYP2C19 not observed 
rCYP2D6 not observed 
rCYP2E1 not observed 
rCYP3A4 not observed 
rFMO control not observed 
rFMO1 not observed 
rFMO3 not observed 
rFMO5 not observed 
 
Experiments with rCYP (100 pmol CYP/mL) or rFMO (100 µg protein/mL) consisted of 
10 µg/mL TATP incubated with 10 mM phosphate buffer (pH 7.4), 2 mM MgCl2 and 1 mM 
reduced nicotinamide adenine dinucleotide phosphate (NADPH). Incubations were done 
in triplicate and quenched at 10 min.  





Table B-2. TATP-O-glucuronide formation from TATP-OH incubations with recombinant 
uridine diphosphoglucuronosyltransferase (rUGT) 
Incubation matrix TATP-O-glucuronide/IS 
area count 
HLM 0.26 ± 0.02 
rUGT control not observed 
rUGT1A1 not observed 
rUGT1A3 not observed 
rUGT1A4 not observed 
rUGT1A6 not observed 
rUGT1A9 not observed 
rUGT2B7 0.05 ± 0.03 
 
Experiments with rUGT (500 µg protein/mL) consisted of 10 µg/mL TATP-OH incubated 
with 10 mM phosphate buffer (pH 7.4), 2 mM MgCl2, 50 µg/mL alamethicin, 1 mM 
NADPH, and 5.5 mM uridine diphosphoglucuronic acid (UDPGA). Glucuronidation done 
in triplicate and quenched at 2 h. Quantification was done using area ratio TATP-O-
glucuronide/internal standard.  
IS internal standard 
 
 
